Released	Title	Price Sensitive	Download	Types
2020-01-02 16:19:00	Appendix 3B	0	https://app.sharelinktechnologies.com/announcement/asx/e5ad789092bfbd7010879b73837ef247	Appendix 3B
2020-01-02 20:19:00	Change of Director's Interest Notice	0	https://app.sharelinktechnologies.com/announcement/asx/2eb6818eb90b80bf2dc2318bf1e592c1	Change of Director's Interest Notice
2020-01-06 08:18:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/aaa09c571db691201c9b6b80a1251032	Change in substantial holding
2020-01-09 08:23:00	Immutep expands Part C of TACTI-002 due to positive data	1	https://app.sharelinktechnologies.com/announcement/asx/47910ea43d2713ca397ac8af8ad1be72	Progress Report
2020-01-10 09:53:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/a7fd38a935c3275f382bb160e4558862	Company Presentation
2020-01-29 09:02:00	Appendix 4C - quarterly	1	https://app.sharelinktechnologies.com/announcement/asx/6428a30f670273adc8b1a10d25095f9f	Commitments Test Entity - Second Quarter Report
2020-01-29 09:41:00	Immutep Activities Report	1	https://app.sharelinktechnologies.com/announcement/asx/a3f4f153a0edee79294f260620ecb774	Second Quarter Activities Report
2020-02-04 08:19:00	Immutep to present TACTI-002 data at German Cancer Congress	0	https://app.sharelinktechnologies.com/announcement/asx/e6a41a9e9c1b4bf14db87a900ec880bd	Progress Report - Other
2020-02-05 08:51:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/50eb0b8d6d06f77ece99d6d2056445b1	Change in substantial holding
2020-02-19 08:14:00	Immutep reports positive TACTI-002 data	1	https://app.sharelinktechnologies.com/announcement/asx/b7c9a7a243c8b172e097612af1d0c755	Progress Report Web Casts
2020-02-21 08:14:00	Half Yearly Report and Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/051f24747f536a07cf2413d6d0c2d00f	Half Yearly Report Half Year Audit Review Half Year Directors' Statement Half Year Accounts Half Year Directors' Report
2020-02-21 08:16:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/4a956a9d5c2f06e81f0c146bdd00c46b	Change in substantial holding
2020-02-25 17:41:00	Immutep Clinical Update & Results Global Webcast Slides	0	https://app.sharelinktechnologies.com/announcement/asx/58fbffc24df5929773ba949289d870f1	Company Presentation Progress Report
2020-03-02 08:17:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/3a8f6652f54e0ac582282001ef3bbf02	Change in substantial holding
2020-03-09 08:26:00	Immutep receives 2nd IND approval for efti from US FDA	1	https://app.sharelinktechnologies.com/announcement/asx/54fe5adbc4d0d3dd32e2245cb039ad1b	Progress Report
2020-03-16 16:54:00	Change of Director's Interest Notice - Mr Chamberlain	0	https://app.sharelinktechnologies.com/announcement/asx/75c922ab5a40d31c547f9651ac4e8e53	Change of Director's Interest Notice
2020-03-20 08:25:00	Immutep's Partner, EOC completes recruitment of Phase 1	0	https://app.sharelinktechnologies.com/announcement/asx/7ceb921609e81a30ecd87676cd093327	Progress Report
2020-03-25 09:24:00	Immutep reports supportive efficacy data from AIPAC study	1	https://app.sharelinktechnologies.com/announcement/asx/7789496ba75a48f3026b3b3115fbff5e	Progress Report
2020-03-26 08:29:00	Immutep AIPAC Ph2b Clinical Results & Update Webcast Slides	1	https://app.sharelinktechnologies.com/announcement/asx/1e1a0d3a469c8909a2f3004ea6009974	Company Presentation Progress Report
2020-04-08 11:17:00	EOC Pharma confirms plans to advance Efti in China for MBC	1	https://app.sharelinktechnologies.com/announcement/asx/1a14971d3d6caf358f0df35e5b1eb33a	Progress Report
2020-04-14 11:30:00	Immutep presents TACTI-002 data at AACR Virtual Meeting	1	https://app.sharelinktechnologies.com/announcement/asx/08054425814472ece485e5ff4c3d0cf8	Company Administration - Other
2020-04-16 08:53:00	Immutep advances its LAG-3 agonist for autoimmune diseases	1	https://app.sharelinktechnologies.com/announcement/asx/743a76f3ea82177db55392fa0d24490e	Progress Report
2020-04-20 10:19:00	Immutep March Quarterly Activities Report & Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/a969887f48433c9f02d269d8b8b83210	Commitments Test Entity - Third Quarter Report Commitments Test Entity - Third Quarter Activity Report
2020-04-22 08:17:00	Enrollment completed for the INSIGHT-004 Study	1	https://app.sharelinktechnologies.com/announcement/asx/5bb9d47a1f3fb5bc92baed8533aa5a01	Progress Report
2020-04-27 09:21:00	Trading Halt	1	https://app.sharelinktechnologies.com/announcement/asx/f847a3dcf7fff3166ebc3ba2028c75c8	Trading Halt
2020-04-28 09:55:00	Immutep Reports Positive Phase II TACTI-002 Data	1	https://app.sharelinktechnologies.com/announcement/asx/5c1a58180200db3fca70d465f4548b26	Progress Report
2020-04-29 09:28:00	Immutep Investor Presentation	1	https://app.sharelinktechnologies.com/announcement/asx/3ac5e3d34c2f0a8852d4ab0a1744f984	Company Presentation
2020-04-29 09:28:00	Immutep completes A$12 million placement	1	https://app.sharelinktechnologies.com/announcement/asx/49617b4c83b8caad9aeefc4624f89356	Placement
2020-04-29 09:44:00	Proposed issue of Securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/56f7d1aac0310b8330caa3d3f979579e	Appendix 3B Trading Halt Lifted
2020-04-29 09:54:00	Proposed issue of Securities - IMM	1	https://app.sharelinktechnologies.com/announcement/asx/86d7752d62e95fa64b21bd74634a5933	Appendix 3B Trading Halt Lifted
2020-04-30 08:57:00	INSIGHT-004 and TACTI-002 data to be presented at ASCO	1	https://app.sharelinktechnologies.com/announcement/asx/2d9353a5a438d85510c11164a8458b24	Progress Report Web Casts
2020-05-01 08:20:00	Immutep presents at NWR Virtual Small Cap Health Conference	0	https://app.sharelinktechnologies.com/announcement/asx/77d2348073393d18ba5006ad3cf5a6d9	Web Casts
2020-05-04 11:13:00	Appendix 2A	0	https://app.sharelinktechnologies.com/announcement/asx/591b5d69ef5c0464a5d61334376b0df5	Appendix 2A (Application for Quotation of Securities
2020-05-05 10:12:00	Cleansing Notice	0	https://app.sharelinktechnologies.com/announcement/asx/21ecfd92e83a98e148b28e8138cfe987	Cleansing Notice
2020-05-07 08:31:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/8349ac0d58f5301c7999a59b6df22507	Change in substantial holding
2020-05-07 08:49:00	Immutep granted Japanese patent for eftilagimod alpha	1	https://app.sharelinktechnologies.com/announcement/asx/53d0682e2ea5397607e55f8329bbdc03	Progress Report
2020-05-07 12:59:00	Becoming a substantial holder from AEF	0	https://app.sharelinktechnologies.com/announcement/asx/2889739327eda067199e3a2036867a31	Becoming a substantial holder
2020-05-27 08:21:00	Immutep webcast to present new data from 2020 ASCO meeting	0	https://app.sharelinktechnologies.com/announcement/asx/30d3c2bebb9537fa058067ab445e7b8d	Notice of Meeting - Other Web Casts
2020-05-29 08:55:00	Immutep receives $3.6M R&D French tax incentive	1	https://app.sharelinktechnologies.com/announcement/asx/447ad3e96c86f39da0a940dafd77c9b8	Periodic Reports - Other
2020-06-01 08:18:00	Immutep Reports First Results from INSIGHT-004 Study	1	https://app.sharelinktechnologies.com/announcement/asx/bef7b0fbb09aa298b28b891c50fe0dc3	Progress Report
2020-06-01 08:19:00	Immutep announces improving data from TACTI-002 ph II trial	1	https://app.sharelinktechnologies.com/announcement/asx/5625b626e09906f3558d634b00eb0f93	Progress Report
2020-06-22 08:17:00	Immutep receives A$1,437,826 R&D Tax Incentive	1	https://app.sharelinktechnologies.com/announcement/asx/8b956f2f64acbc77559395d44799a549	Periodic Reports - Other
2020-06-29 08:21:00	Immutep Completes Recruitment for Part A of TACTI-002 trial	1	https://app.sharelinktechnologies.com/announcement/asx/71b629f69bb228fbbc94942804c3c33c	Progress Report
2020-07-15 08:14:00	US patent granted for IMP701 antibody	1	https://app.sharelinktechnologies.com/announcement/asx/83c68d140bfa5b640c7c506c62cc4b3a	Progress Report
2020-07-21 08:26:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/4f287e39819c1a9f86f79838c99ceca6	Change in substantial holding
2020-07-23 08:21:00	Immutep Quarterly Activities Report & Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/3bf7b26ba9a281070899341cc32161e1	Commitments Test Entity - Fourth Quarter Report Commitments Test Entity - Fourth Quarter Activity Report
2020-07-27 08:12:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/93187adb13b239ee0b10e4b9ffceeba0	Change in substantial holding
2020-08-11 18:07:00	Lapse of Unlisted Options	0	https://app.sharelinktechnologies.com/announcement/asx/d4196ddc0d820157db12ea10ec45dd7e	Issued Capital - Other
2020-08-11 18:33:00	Immutep granted US patent for eftilagimod alpha	1	https://app.sharelinktechnologies.com/announcement/asx/af80cae65604a061fa2277414abc8d95	Progress Report
2020-08-17 10:14:00	Immutep Investor Update	0	https://app.sharelinktechnologies.com/announcement/asx/42a1570c7dc3c260f2000df5c04c33c7	Progress Report
2020-08-18 08:18:00	Recruitment of stage 1 of part B in TACTI-002 study complete	1	https://app.sharelinktechnologies.com/announcement/asx/9dbf161f0986a0f0b0c299a2f191e494	Progress Report
2020-08-25 18:55:00	Appendix 4E & 2020 Full Year Statutory Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/1f2cd5acea25247cb145d39b37a6df56	Annual Report Top 20 shareholders Preliminary Final Report Full Year Accounts Full Year Audit Review Full Year Directors' Statement Full Year Directors' Report
2020-08-26 08:19:00	New data to be presented at ESMO for eftilagimod alpha	0	https://app.sharelinktechnologies.com/announcement/asx/75245cac9d3aa273d375fd403a6f0592	Progress Report
2020-08-31 08:05:00	IMM & Monash Uni receive funding grant for LAG-3 Research	1	https://app.sharelinktechnologies.com/announcement/asx/9c708876a66bfd8a838ad172c3f0c8c8	Periodic Reports - Other
2020-09-11 16:36:00	2020 AGM & Key Dates	0	https://app.sharelinktechnologies.com/announcement/asx/447c19bbab072ae16512e74d8ed16847	Notice of Meeting - Other Web Casts
2020-09-14 08:19:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/c225a3bce1a3f533b9e7dbf5127ca810	Change in substantial holding
2020-09-18 08:20:00	Immutep reports improving results from INSIGHT-004 trial	1	https://app.sharelinktechnologies.com/announcement/asx/24083d59cc788cd4bd868d9b1e46d7cb	Progress Report
2020-09-18 08:20:00	Improving results from stage 1 of TACTI-002 ph II trial	1	https://app.sharelinktechnologies.com/announcement/asx/66f396ad09b5228a378a97b410fa484a	Progress Report
2020-09-25 10:08:00	Annual Report to shareholders	0	https://app.sharelinktechnologies.com/announcement/asx/1fc36a3d5771e03e73f7cad1db6a63f7	Annual Report Top 20 shareholders Full Year Accounts Full Year Audit Review Full Year Directors' Statement Full Year Directors' Report
2020-09-25 10:14:00	Appendix 4G & Corporate Governance Statement	0	https://app.sharelinktechnologies.com/announcement/asx/aeb2ea4e6310242f387412c952712a08	Corporate Governance Takeover - Appendix 4G
2020-09-25 10:37:00	Notice of Annual General Meeting/Proxy Form	0	https://app.sharelinktechnologies.com/announcement/asx/7cd0daf98bc19bd5b9a265e3446d059d	Notice of Annual General Meeting Proxy Form
2020-09-28 08:18:00	Annual Report filed on Form 20-F with SEC	0	https://app.sharelinktechnologies.com/announcement/asx/b6a5fe327e720ccbff4abb9f0e52bb2a	Annual Report
2020-10-02 16:22:00	Appendix 3G	0	https://app.sharelinktechnologies.com/announcement/asx/557c84ee13b4bacfbf6ace5fb9569789	Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2020-10-02 16:37:00	Appendix 2A	0	https://app.sharelinktechnologies.com/announcement/asx/84b3cc3874588ffbaa96e7a73e6455d1	Appendix 2A (Application for Quotation of Securities
2020-10-05 17:36:00	Change of Director's Interest Notice - Mr Voigt	0	https://app.sharelinktechnologies.com/announcement/asx/80f31b8732100e4b6ce5d974119451a8	Change of Director's Interest Notice
2020-10-05 17:45:00	Change of Director's Interest Notice - Mr Meyers	0	https://app.sharelinktechnologies.com/announcement/asx/f3cc43de9c9e0b8d1adce7b3a8b4a0f8	Change of Director's Interest Notice
2020-10-05 17:50:00	Change of Director's Interest Notice - Mr Chamberlain	0	https://app.sharelinktechnologies.com/announcement/asx/3e64d8877136dd01c61591e6d2d2a52b	Change of Director's Interest Notice
2020-10-06 08:20:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/0233e81bc13261576d276c5cd8243a8a	Change in substantial holding
2020-10-19 10:24:00	Immutep to present AIPAC Overall Survival data at SABCS 2020	0	https://app.sharelinktechnologies.com/announcement/asx/36593b71ab948b007fbfbc2f26e07abe	Company Administration - Other
2020-10-21 15:48:00	Immutep granted European patent for IMP761	1	https://app.sharelinktechnologies.com/announcement/asx/749c9742de772b81690e30271b92e523	Progress Report
2020-10-22 08:33:00	Immutep Quarterly Activities Report & Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/9fb5d5e39f44c00da7fe25fe6550a73b	Commitments Test Entity - First Quarter Report Commitments Test Entity - First Quarter Activity Report
2020-10-23 08:21:00	COVID-19 phase 2 investigator initiated trial commences	1	https://app.sharelinktechnologies.com/announcement/asx/7d93de7dd37fc746d111a6dc10a937fd	Progress Report
2020-10-27 08:13:00	Chairman's AGM Address	0	https://app.sharelinktechnologies.com/announcement/asx/b4f7bb56a07ba977f10875a5f5406b66	Chairman's Address to Shareholders
2020-10-27 08:13:00	2020 AGM Presentation	1	https://app.sharelinktechnologies.com/announcement/asx/e0ede5ca3d358ee9d8996f1f0e402915	Company Presentation Chairman's Address to Shareholders
2020-10-27 15:35:00	Results of Meeting	0	https://app.sharelinktechnologies.com/announcement/asx/e55447cb4603bd2ec351ea11dd4f36a6	Results of Meeting
2020-10-30 08:13:00	Immutep enters into a Licence & Collaboration with LabCorp	1	https://app.sharelinktechnologies.com/announcement/asx/e439ff1e97635c2b20ccfece54eb09cb	Progress Report
2020-11-02 16:12:00	Lapse of Unlisted Options	0	https://app.sharelinktechnologies.com/announcement/asx/da0cb35c6e91017ed55f0178e1e3abaf	Issued Capital - Other
2020-11-03 09:30:00	Immutep to present TACTI-002 phase 2 data at SITC 2020	0	https://app.sharelinktechnologies.com/announcement/asx/c71301a08d3160c07b6b4e690df12536	Progress Report
2020-11-06 17:15:00	Proposed issue of Securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/659b012adc6c0e1ac89235ed4e5c6f8b	Appendix 3B
2020-11-06 17:23:00	Appendix 3G	0	https://app.sharelinktechnologies.com/announcement/asx/7f522a8aa7b5210cd322416c8c871c87	Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2020-11-06 17:35:00	Change of Director's Interest Notice - Grant Chamberlain	0	https://app.sharelinktechnologies.com/announcement/asx/8130f31e726cba9414a34bf189c6e135	Change of Director's Interest Notice
2020-11-09 09:26:00	Immutep Announces Australian Patent Grant for IMP701	1	https://app.sharelinktechnologies.com/announcement/asx/c5ae330178a865efb850de66d83d3408	Progress Report
2020-11-10 07:30:00	Encouraging Phase II TACTI-002 data reported at SITC 2020	1	https://app.sharelinktechnologies.com/announcement/asx/ea34df0156a99577c4c2fcb9fefca877	Progress Report
2020-11-17 12:51:00	Pause in Trading	1	https://app.sharelinktechnologies.com/announcement/asx/9929052edbe0f37a69962a4e27ca78e8	Notice Pending
2020-11-17 13:29:00	Trading Halt	1	https://app.sharelinktechnologies.com/announcement/asx/1b56932a49e2bd3b0f074614d7dbdc67	Trading Halt
2020-11-18 08:41:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/eede1ea5acb2ed567e1c80f7eb19de2c	Change in substantial holding
2020-11-19 09:19:00	Immutep expands TACTI-002 Collaboration Trial with MSD	1	https://app.sharelinktechnologies.com/announcement/asx/5a3806825f1d7d677bd88bc4b5bc66fa	Progress Report
2020-11-19 09:20:00	Proposed issue of Securities - IMM	1	https://app.sharelinktechnologies.com/announcement/asx/81dfdddb30ce496338b45f890ec6596f	Appendix 3B Trading Halt Lifted
2020-11-19 09:20:00	Immutep Investor Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/2b60ccba69e294a75371607111593b98	Company Presentation
2020-11-19 09:20:00	Immutep completes a A$29.6 million placement	1	https://app.sharelinktechnologies.com/announcement/asx/a432be61cb0dede161da967c9cfb3471	Placement
2020-11-24 11:08:00	Appendix 2A	0	https://app.sharelinktechnologies.com/announcement/asx/ab66049b3fe42ddb0553bc4ac7e7f3e8	Appendix 2A (Application for Quotation of Securities
2020-11-24 13:17:00	Change of substantial holding from AEF	0	https://app.sharelinktechnologies.com/announcement/asx/b97c3f8a7582e15e66d330c3841c8a34	Change in substantial holding
2020-11-25 09:58:00	Cleansing Notice	0	https://app.sharelinktechnologies.com/announcement/asx/39a14fcb7d3e6229c27981f75b66505e	Cleansing Notice
2020-11-27 08:20:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/25209edffacf9299f04c1437dbdc22e3	Change in substantial holding
2020-11-27 12:26:00	Change in substantial holding from AEF	0	https://app.sharelinktechnologies.com/announcement/asx/80f235c7f8f34dc7a40621ddac2a545a	Change in substantial holding
2020-12-10 08:21:00	Overall Survival data from ph IIb AIPAC breast cancer trial	1	https://app.sharelinktechnologies.com/announcement/asx/7c3088b95b03020d98e6c5617db9a8a2	Progress Report
2020-12-10 09:24:00	Immutep's partner EOC pharma to start Ph II trial in MBC	1	https://app.sharelinktechnologies.com/announcement/asx/42d9cd3f958376413d320eafd03a6768	Progress Report
2020-12-11 08:19:00	Webcast slides for AIPAC Phase IIb breast cancer trial	0	https://app.sharelinktechnologies.com/announcement/asx/8bf06a0fde3816c05b6cf83bbb0c5445	Company Presentation
2020-12-11 17:07:00	Appendix 2A	0	https://app.sharelinktechnologies.com/announcement/asx/95db9e6fce6d754dbe20d6eda883574a	Appendix 2A (Application for Quotation of Securities
2020-12-15 08:19:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/3167b0eb9b1c737d70665fa303957c13	Change in substantial holding
2020-12-15 16:27:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/f7191a6c316a2d6f79382a48b6d5f9ad	Ceasing to be a substantial holder
2020-12-15 19:19:00	Operational Update	1	https://app.sharelinktechnologies.com/announcement/asx/6b04cd957563b94d41d100c7283eff23	Progress Report
2020-12-16 08:19:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/fae26629b0bcf00a7c9a24209973d2cb	Change in substantial holding
2020-12-16 18:59:00	Immutep Upscales Efti Manufacturing	1	https://app.sharelinktechnologies.com/announcement/asx/23a9647cdb0869aa984cf697c5975e57	Progress Report
2020-12-17 08:24:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/fe20df95d31613bae00a56e9e39c8a8b	Change in substantial holding
2020-12-18 08:21:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/edaf5928765344e413b4b16b0c253548	Change in substantial holding
2020-12-24 09:58:00	Becoming a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/2b5f175ed27e1dbd64ffac1f8de31f1d	Becoming a substantial holder
2020-12-24 14:39:00	Appendix 2A	0	https://app.sharelinktechnologies.com/announcement/asx/12a7f5217dc6ce03623d6b23a5d1baec	Appendix 2A (Application for Quotation of Securities
2020-12-24 15:04:00	Change of Director's Interest Notice - Dr Howard	0	https://app.sharelinktechnologies.com/announcement/asx/3674a9adf38a1260a4dbcdf00f1bf7b8	Change of Director's Interest Notice
2020-12-29 08:33:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/54426fb3a187c7ef981c214735015909	Change in substantial holding
2020-12-30 08:20:00	Immutep granted US patent for eftilagimod alpha with a PD-1	1	https://app.sharelinktechnologies.com/announcement/asx/bc4d64796a63339031bf493805dbadf7	Progress Report
2020-12-30 08:22:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/c8713684e5f4b58a1deeba1337be55e9	Change in substantial holding
2020-12-31 08:25:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/e67c42592cfe9fddd4cf71fa2046eacc	Change in substantial holding
2020-12-31 12:11:00	Appendix 2A	0	https://app.sharelinktechnologies.com/announcement/asx/cb0173a9f76ef3af3c118d4aa65a120d	Appendix 2A (Application for Quotation of Securities
2021-01-04 09:16:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/745764e250343935ede96c7044830b1a	Change of Director's Interest Notice
2021-01-04 16:32:00	Resignation and Appointment of Joint Company Secretary	0	https://app.sharelinktechnologies.com/announcement/asx/d8c5bf92b18678789fa4c3486951db82	Company Secretary Appointment/Resignation
2021-01-07 09:33:00	Recruitment of head & neck cancer patients completed for ph2	1	https://app.sharelinktechnologies.com/announcement/asx/b282f0aa912f4eba67e545561e46fe27	Progress Report
2021-01-22 08:54:00	Ulcerative Colitis Phase II Study of GSK2831781 Discontinued	1	https://app.sharelinktechnologies.com/announcement/asx/b49361c2e4d8ba470d13bbe9fa49688d	Progress Report
2021-01-22 08:57:00	Immutep Quarterly Activities Report & Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/134e88f9e15ce676a5042cb5cf1a075d	Commitments Test Entity - Second Quarter Report Commitments Test Entity - Second Quarter Activity Report
2021-01-27 08:59:00	Phase II study for eftilagimod alpha in COVID-19 advances	1	https://app.sharelinktechnologies.com/announcement/asx/664902db7240bb7cba5c66d7b3423171	Progress Report
2021-02-02 08:22:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/582866b95d1c209f5b4f6d1c7e5f1de3	Company Presentation
2021-02-23 16:23:00	Half Yearly Report and Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/2c9b08f6edafcf14750d2c177dcf3351	Half Yearly Report Half Year Audit Review Half Year Directors' Statement Half Year Accounts Half Year Directors' Report
2021-03-05 08:21:00	Immutep expands Part B of TACTI-002 collaboration trial	1	https://app.sharelinktechnologies.com/announcement/asx/bbb1d7514ab72d46e000dcee74501110	Progress Report
2021-03-09 16:14:00	Immutep secures second US patent grant for eftilagimod alpha	1	https://app.sharelinktechnologies.com/announcement/asx/41f6b9048f935597ea6e893eff2f0ca2	Progress Report
2021-03-12 17:02:00	S&P DJI Announces March 2021 Quarterly Rebalance	1	https://app.sharelinktechnologies.com/announcement/asx/c4537e50aec7075a471239bf8c2eda5b	Standard and Poor's Announcement
2021-03-16 08:17:00	Immutep collaborates with MSD for phase 2b head & neck trial	1	https://app.sharelinktechnologies.com/announcement/asx/7643ce43da10739415e60b72c6637357	Progress Report
2021-03-18 10:59:00	Appendix 2A	0	https://app.sharelinktechnologies.com/announcement/asx/73059327bf6361943da9adde0989e2ca	Appendix 2A (Application for Quotation of Securities
2021-04-01 08:22:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/385257157ffb8eb99ad6db3df55a79f6	Change in substantial holding
2021-04-07 08:28:00	Immutep announces European Patent Grant for LAG525	1	https://app.sharelinktechnologies.com/announcement/asx/39a5bf1b616c166cad4fb356fb62458f	Progress Report
2021-04-08 07:52:00	Immutep achieves Fast Track designation for Efti from US FDA	1	https://app.sharelinktechnologies.com/announcement/asx/a7e3d93fdbadd8d404a04d98ae1a9102	Progress Report
2021-04-14 09:25:00	Immutep Investor Update	0	https://app.sharelinktechnologies.com/announcement/asx/eb22db530362edbf05a023e891d31bd6	Periodic Reports - Other
2021-04-16 17:46:00	Immutep receives A$1,155,055 R&D Tax Incentive	1	https://app.sharelinktechnologies.com/announcement/asx/f58f0089b468a9eeb40e7d741b629853	Periodic Reports - Other
2021-04-19 09:40:00	Immutep Quarterly Activities Report & Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/0c7a329b28494d856af0df7495318cc3	Commitments Test Entity - Third Quarter Report Commitments Test Entity - Third Quarter Activity Report
2021-04-29 07:31:00	TACTI-002 & INSIGHT-004 data to be presented at ASCO	1	https://app.sharelinktechnologies.com/announcement/asx/0fbcf95f9d00a58dbfe5737ae93ebf8d	Progress Report
2021-05-07 09:49:00	Operational Update	1	https://app.sharelinktechnologies.com/announcement/asx/65107ca1c65ece41c5091bc4c7e527af	Progress Report
2021-05-13 11:51:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/b11fba3d9bac3dcef04ce7b0c4b7bd81	Company Presentation
2021-05-14 10:55:00	Appendix 2A	0	https://app.sharelinktechnologies.com/announcement/asx/7fb4ed5ef6cb4aab03bcb32ac19d14dc	Appendix 2A (Application for Quotation of Securities
2021-05-18 08:20:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/8b3f3a2d6233ca833f44e3da4fd9c7c1	Change in substantial holding
2021-05-20 08:22:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/ff4afb46385008c041a9b8b405c4a5d0	Change in substantial holding
2021-05-20 13:07:00	TACTI-002 and INSIGHT-004 abstracts for ASCO 2021	0	https://app.sharelinktechnologies.com/announcement/asx/bef8c6c7c58dacf7c66883287f0d7c21	Progress Report - Other
2021-05-25 08:16:00	Immutep to present at Jefferies Healthcare Conference	0	https://app.sharelinktechnologies.com/announcement/asx/605d69ed40c022f99950f4e6fa278491	Web Casts
2021-05-26 13:32:00	Immutep granted Chinese patent for its LAG-3 candidate Efti	1	https://app.sharelinktechnologies.com/announcement/asx/5c1429f315dc3790d185d8b2283184f6	Progress Report
2021-06-01 08:20:00	Immutep enters New Collaboration with Merck KGaA for Efti	1	https://app.sharelinktechnologies.com/announcement/asx/11a993942460c351e34f2d6feb4af49b	Progress Report
2021-06-02 11:13:00	Immutep granted European patent for its LAG-3 candidate Efti	1	https://app.sharelinktechnologies.com/announcement/asx/e90b85fa55acf843846b49cce6ffcf0f	Progress Report
2021-06-04 16:14:00	Immutep Reports Positive Final Data from INSIGHT-004 trial	1	https://app.sharelinktechnologies.com/announcement/asx/5637138be503b944b141e6ce009cf008	Progress Report
2021-06-04 16:17:00	Immutep Reports Positive Data from its TACTI-002 ph 2 trial	1	https://app.sharelinktechnologies.com/announcement/asx/08fcddd4325d30cccf9d542c4c58655f	Progress Report Web Casts
2021-06-04 16:19:00	Immutep presentation for Jefferies Healthcare Conference	0	https://app.sharelinktechnologies.com/announcement/asx/8701ce847fe4795edca20698d8425f9a	Company Presentation
2021-06-07 16:01:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/b0b347467f1c67446c218755eaf2e112	Appendix 2A (Application for Quotation of Securities
2021-06-08 07:37:00	Immutep Reveals a New anti-LAG-3 Research Program	1	https://app.sharelinktechnologies.com/announcement/asx/99e8bedefdaa831eb19915a6b3281903	Progress Report
2021-06-08 16:11:00	Appendix 2A	0	https://app.sharelinktechnologies.com/announcement/asx/ecad5c766040f0d922e86cd5af3235a5	Appendix 2A (Application for Quotation of Securities
2021-06-09 19:21:00	Immutep global webcast slides	1	https://app.sharelinktechnologies.com/announcement/asx/f9b7f433005f5f54b0a5ab7912883edb	Company Presentation Web Casts
2021-06-15 08:17:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/8e5592a98ea23511fcb7184e69ebf3ca	Change in substantial holding
2021-06-17 08:20:00	Trading Halt	1	https://app.sharelinktechnologies.com/announcement/asx/41936ead4cd5a523509d3eafb78fad91	Trading Halt
2021-06-21 09:47:00	Immutep secures commitments for A$60 million in a Placement	1	https://app.sharelinktechnologies.com/announcement/asx/a19a324728fe82f5d6036ddefbdb5715	Placement Issued Capital - Other Security Purchase Plan Trading Halt Lifted Company Administration - Other
2021-06-21 09:47:00	Immutep Capital Raising Presentation	1	https://app.sharelinktechnologies.com/announcement/asx/3b8f689fc06fcbb5015f353dfb9806aa	Company Presentation
2021-06-21 09:48:00	Efti to be evaluated in new triple combination therapy trial	1	https://app.sharelinktechnologies.com/announcement/asx/944de89bb3de4a254cc1f87076ad370c	Progress Report
2021-06-21 09:48:00	Proposed issue of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/590386b1585cfd8efe4ee8506973d218	Appendix 3B
2021-06-25 11:39:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/b9e13bbb4fa49f71df87e24bf837af56	Appendix 2A (Application for Quotation of Securities
2021-06-25 16:04:00	Share Purchase Plan Offer Documents	0	https://app.sharelinktechnologies.com/announcement/asx/df23b9bcb2f8c5b1b0a31e14eff41c7c	Security Purchase Plan Letter to Shareholders
2021-06-25 16:15:00	Notice of Extraordinary General Meeting/Proxy Form	0	https://app.sharelinktechnologies.com/announcement/asx/9d5d343faa5eb2761f66006ae297d60b	Notice of Extraordinary General Meeting Proxy Form
2021-06-28 08:11:00	Cleansing Notice	0	https://app.sharelinktechnologies.com/announcement/asx/219dcbf79a2dc532609951f56fb117c4	Cleansing Notice
2021-06-30 08:19:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/55f99639fe98995325ac2daeb882cf34	Ceasing to be a substantial holder
2021-06-30 12:28:00	Change in substantial holding from AEF	0	https://app.sharelinktechnologies.com/announcement/asx/61a5614e8a30da23b962b4b2c91d6e87	Change in substantial holding
2021-07-05 16:34:00	Proposed issue of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/7872159a956938d7d471562ffb7c171b	Appendix 3B
2021-07-06 08:58:00	US FDA & IRB approves start of ph2b head & neck cancer trial	1	https://app.sharelinktechnologies.com/announcement/asx/0b9d71777ef1bd3cbd33a70ee3aef1c2	Progress Report
2021-07-13 09:48:00	Immutep Quarterly Activities Report & Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/c1742ebd49f96db1399ca9641226d13e	Commitments Test Entity - Fourth Quarter Report Commitments Test Entity - Fourth Quarter Activity Report
2021-07-15 13:10:00	EGM - Now to be Held as an Online Virtual Meeting	0	https://app.sharelinktechnologies.com/announcement/asx/a36435de51c81afc7d92212918106c77	Notice of Meeting - Other Web Casts
2021-07-21 09:00:00	Completion of Share Purchase Plan	1	https://app.sharelinktechnologies.com/announcement/asx/d55a0c77b19929af14b4239f6b75b11a	Issued Capital - Other Security Purchase Plan
2021-07-23 08:25:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/d1fc971a2866361ec311f5aa157aa650	Change in substantial holding
2021-07-23 08:25:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/0a1ccb4455027c2ec08a701650d9af65	Appendix 2A (Application for Quotation of Securities
2021-07-26 11:56:00	2021 EGM Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/f10312319d80acbce69c18ecfd259d44	Company Presentation
2021-07-26 12:04:00	Chairman's EGM Address	0	https://app.sharelinktechnologies.com/announcement/asx/d560eaa15d64f0d5f07dfcf637e686b5	Chairman's Address to Shareholders
2021-07-26 18:37:00	Results of EGM	0	https://app.sharelinktechnologies.com/announcement/asx/b928c3771ba7ce5d2ae41f37c1e7f38b	Results of Meeting
2021-07-27 08:15:00	Proposed issue of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/da000531257c421e2801e91309b5eee8	Appendix 3B
2021-07-27 08:19:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/225ff93f0931bddc2021042e7ec46e6d	Change in substantial holding
2021-07-29 08:22:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/bc65adefe6e522d5efe382b9a0b7ec57	Appendix 2A (Application for Quotation of Securities
2021-07-30 09:24:00	Completion of Placement - Tranche 2	1	https://app.sharelinktechnologies.com/announcement/asx/d14e7c81279f79065a955a473fd062ec	Placement
2021-07-30 10:03:00	Cleansing Notice	0	https://app.sharelinktechnologies.com/announcement/asx/926f48d93f7fda9edcad84be555e7ca6	Cleansing Notice
2021-08-03 08:21:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/ca6dc040baa03420b9619e75b58d547b	Change in substantial holding
2021-08-03 19:18:00	Becoming a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/4bc0db212051d228aeb70df0808bc605	Becoming a substantial holder
2021-08-05 08:18:00	INSIGHT-003 investigator-initiated trial - 1st patient dosed	1	https://app.sharelinktechnologies.com/announcement/asx/6cead79bcb3c82fde88d5f347d415107	Progress Report
2021-08-27 08:04:00	Chinese patent granted for anti-LAG-3 antibody LAG525	1	https://app.sharelinktechnologies.com/announcement/asx/ed73b96655191eb3ebc84098357a844f	Progress Report
2021-08-30 19:08:00	Appendix 4E & 2021 Full Year Statutory Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/86dbf512036b38e34ff51d1b390db197	Annual Report Top 20 shareholders Preliminary Final Report Full Year Accounts Full Year Audit Review Full Year Directors' Statement Full Year Directors' Report Corporate Governance
2021-08-31 08:46:00	Immutep's partner, EOC Pharma, expands efti trial pipeline	1	https://app.sharelinktechnologies.com/announcement/asx/1311bd70fafe93f8a246910e17c235ee	Progress Report
2021-09-01 10:07:00	Recruitment of patients completed for Part B of TACTI-002	1	https://app.sharelinktechnologies.com/announcement/asx/c67d3418fb751a5fa7577505cb8c91b1	Progress Report
2021-09-21 18:38:00	Immutep to present final AIPAC Overall Survival data at SITC	0	https://app.sharelinktechnologies.com/announcement/asx/5156847da7a212d1a9de72f125c39e29	Progress Report Company Administration - Other
2021-09-27 18:37:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/b6154f501fe21cfdd17b7fc80d19143b	Company Presentation
2021-09-28 12:09:00	Immutep to Present at Healthcare Investor Conferences	0	https://app.sharelinktechnologies.com/announcement/asx/774a4d56eb2f56ccfeaa1e37ef5e464d	Web Casts
2021-09-29 08:47:00	Immutep Receives A$3.4 million R&D French Tax Incentive	1	https://app.sharelinktechnologies.com/announcement/asx/e99859ed8d6f1d1986dbeb05bfe5f9c9	Progress Report Company Administration - Other
2021-10-01 11:55:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/6cfea084902d5c66a2ea4dbc313eb6e4	Appendix 2A (Application for Quotation of Securities
2021-10-01 16:16:00	Notification regarding unquoted securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/991ca2dd442f81448e391b132ec3e36d	Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2021-10-04 08:24:00	Immutep to present Phase II TACTI-002 data at SITC 2021	0	https://app.sharelinktechnologies.com/announcement/asx/3c075f3eb1be075178cff9a3ad69405e	Progress Report
2021-10-04 09:25:00	Change of Director's Interest Notice - Mr Meyers	0	https://app.sharelinktechnologies.com/announcement/asx/cfbcb7d8a4fd5eb695e33b1671e68707	Change of Director's Interest Notice
2021-10-04 09:27:00	Change of Director's Interest Notice - Mr Chamberlain	0	https://app.sharelinktechnologies.com/announcement/asx/3369f3c41c53303c5f96f4ecbc17596e	Change of Director's Interest Notice
2021-10-07 08:46:00	Ceasing to be a substantial holder from AEF	0	https://app.sharelinktechnologies.com/announcement/asx/0ce4ad84fd3333f1204b5785fe2bb2e0	Ceasing to be a substantial holder
2021-10-12 19:03:00	2021 AGM & Key Dates	0	https://app.sharelinktechnologies.com/announcement/asx/c83c36b48c4350fdee205cb15fa3ca66	Notice of Meeting - Other
2021-10-26 09:05:00	Annual Report filed on Form 20-F with SEC	0	https://app.sharelinktechnologies.com/announcement/asx/891c87830897ce4d5c969a183540a428	Annual Report
2021-10-26 09:14:00	Annual Report to shareholders	0	https://app.sharelinktechnologies.com/announcement/asx/06713e913038d3cf46e27aa7bc95a99e	Annual Report Top 20 shareholders Full Year Accounts Full Year Audit Review Full Year Directors' Statement Full Year Directors' Report
2021-10-26 09:39:00	Appendix 4G	0	https://app.sharelinktechnologies.com/announcement/asx/763775cf42cedaa11b603cf08c108d9f	Takeover - Appendix 4G
2021-10-26 10:35:00	Notice of Annual General Meeting/Proxy Form	0	https://app.sharelinktechnologies.com/announcement/asx/6f48101f02d6674a56f47cb8804d76e3	Notice of Annual General Meeting Proxy Form
2021-10-28 08:30:00	Immutep Quarterly Activities Report & Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/855fce1e934f3c0385997495db732dae	Commitments Test Entity - First Quarter Report Commitments Test Entity - First Quarter Activity Report
2021-10-29 08:19:00	Immutep receives EMA scientific advice for Phase 3 in MBC	1	https://app.sharelinktechnologies.com/announcement/asx/ca244b6daefe038f50d8411b5d6e33a8	Progress Report Company Administration - Other
2021-11-02 10:57:00	Immutep granted Chinese Patent for eftilagimod alpha	1	https://app.sharelinktechnologies.com/announcement/asx/d6654fa7dbb3580ce94afb08c97e4429	Progress Report
2021-11-08 16:18:00	JobKeeper Payment Notice	0	https://app.sharelinktechnologies.com/announcement/asx/b8aad393fc0a75dcf0b503fc3b4cba5f	Periodic Reports - Other
2021-11-10 08:24:00	Final Phase IIb AIPAC clinical trial results for Efti in MBC	1	https://app.sharelinktechnologies.com/announcement/asx/b53092617dbfa6d862ec000ef13df73f	Progress Report
2021-11-10 08:24:00	Immutep announces publication of SITC 2021 abstracts	1	https://app.sharelinktechnologies.com/announcement/asx/684d9f6ae38f620630aedc945a0b08aa	Progress Report Company Administration - Other
2021-11-15 08:37:00	Chinese Patent Granted for Efti with PD-1 Pathway Inhibitors	1	https://app.sharelinktechnologies.com/announcement/asx/3090f8a5cac202c64488a0890c4d65a6	Progress Report
2021-11-15 08:37:00	Immutep announces publication of SITC 2021 posters	1	https://app.sharelinktechnologies.com/announcement/asx/e251b3b86c5dd8b811c47b44abddccba	Progress Report Web Casts
2021-11-16 18:19:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/96153bffcddaa46a61baaab412e8f7b9	Change in substantial holding
2021-11-17 07:30:00	Immutep Global Webcast Slides to Discuss Clinical Results	1	https://app.sharelinktechnologies.com/announcement/asx/197511d1eae1c986a4f919e533259060	Company Presentation
2021-11-17 08:17:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/f13ec698c2dd728de6589a1c1e35c25c	Change in substantial holding
2021-11-19 08:30:00	Phase II TACTI-002 trial recruitment successfully completed	1	https://app.sharelinktechnologies.com/announcement/asx/fc72d114de30e049da50e3054ad4c3a0	Progress Report
2021-11-26 08:16:00	Immutep AGM 2021 - Chairman's Address	0	https://app.sharelinktechnologies.com/announcement/asx/212adc0869702b1df7c9cddea9d7e6ed	Chairman's Address to Shareholders
2021-11-26 08:17:00	Immutep AGM 2021 - CEO's Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/d7cd08eb52aa9ca1a906cd8b18ed14da	Company Presentation Chairman's Address to Shareholders
2021-11-26 12:35:00	Results of Meeting	0	https://app.sharelinktechnologies.com/announcement/asx/e8e6b723bd8237bb629ba987ae25b92b	Results of Meeting
2021-11-30 14:15:00	Notification regarding unquoted securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/c98734468564b37ba1b1157cbe6a3648	Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2021-11-30 14:26:00	Proposed issue of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/59bd1164d7bcd45f25fae73f8484e803	Appendix 3B
2021-12-01 17:27:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/3f6b7296b0e86c88dea0a20b6509a32d	Appendix 2A (Application for Quotation of Securities
2021-12-01 17:44:00	Change of Director's Interest Notice - Mr Voigt	0	https://app.sharelinktechnologies.com/announcement/asx/f825777804a92c2bd8dbf272d2c22a82	Change of Director's Interest Notice
2021-12-01 17:46:00	Change of Director's Interest Notice - Dr. Howard	0	https://app.sharelinktechnologies.com/announcement/asx/f1815d607d71d2288f30094edbfcfc9b	Change of Director's Interest Notice
2021-12-02 08:22:00	Good safety reported from 1st five patients in INSIGHT-003	1	https://app.sharelinktechnologies.com/announcement/asx/278faf2976f68418b87ab5936e881556	Progress Report
2021-12-02 19:41:00	Notification regarding unquoted securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/7405ee816f92aab7ced121588aab5f6b	Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2021-12-06 08:22:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/d2865d515a3aa7c6994a6ae07a86737f	Change in substantial holding
2021-12-14 16:10:00	Amended Constitution	0	https://app.sharelinktechnologies.com/announcement/asx/d322b7f2f1078e2cdb5ca0586aac9d2c	Constitution
2021-12-14 16:14:00	Change of Registered Office Address	0	https://app.sharelinktechnologies.com/announcement/asx/1aff9c0d4f9a45dedabde63328e3013f	Details of Company Address Details of Registered office address
2021-12-16 08:20:00	Immutep Advances IMP761 Manufacturing	1	https://app.sharelinktechnologies.com/announcement/asx/82fcbe1c20c94827f4d4e8d93dcb7cdc	Progress Report
2022-01-05 08:23:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/68b4f992386bb08378057895bdcebb58	Change in substantial holding
2022-01-25 08:18:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/4a3e6c13c5558961ad5dbd389b23b90d	Commitments Test Entity - Second Quarter Report Commitments Test Entity - Second Quarter Activity Report
2022-01-31 10:40:00	Immutep to present at February Investor Conferences	0	https://app.sharelinktechnologies.com/announcement/asx/6cfa770eaced730dcaecc031b49fe364	Company Administration - Other
2022-02-02 08:18:00	Death of Director Grant Chamberlain	0	https://app.sharelinktechnologies.com/announcement/asx/084abc62060998f4ee955bee9699a68c	Director Appointment/Resignation Company Administration - Other
2022-02-02 08:25:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/2e5993101c8054e77ec6bb305e5790c1	Change in substantial holding
2022-02-11 11:58:00	Australian Patent Granted for Efti with PD-1 Inhibitors	1	https://app.sharelinktechnologies.com/announcement/asx/edb563fd051e9837debff3b4885379be	Progress Report
2022-02-18 08:11:00	Immutep Investor Update	0	https://app.sharelinktechnologies.com/announcement/asx/267f049f95b551f6555fd13c25e3f90c	Periodic Reports - Other Progress Report
2022-02-18 08:13:00	Immutep to present new data from TACTI-002 at ELCC 2022	0	https://app.sharelinktechnologies.com/announcement/asx/66513e4f533788ddf178350a54217c10	Progress Report Company Administration - Other
2022-02-23 18:22:00	Half Yearly Report and Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/92b1c65f465fa6fe77e507baec5c2f26	Half Yearly Report Half Year Audit Review Half Year Directors' Statement Half Year Accounts Half Year Directors' Report
2022-02-24 08:01:00	Immutep to Present at Healthcare Investor Conferences	0	https://app.sharelinktechnologies.com/announcement/asx/76769f5f0d4fb408707b1590d2088296	Company Administration - Other Web Casts
2022-02-25 08:01:00	Appointment of Non-Executive Director	0	https://app.sharelinktechnologies.com/announcement/asx/9eb9d44559534aad168a87d1fcb59112	Director Appointment/Resignation
2022-02-25 15:42:00	Proposed issue of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/f66d1d338b54bac73d9b6bb732167cdf	Appendix 3B
2022-02-25 15:51:00	Initial Director's Interest Notice - Lucy Turnbull	0	https://app.sharelinktechnologies.com/announcement/asx/0a703f16a8f58a7ffbc2ec3bd93af617	Initial Director's Interest Notice
2022-03-10 08:25:00	Immutep receives FDA feedback for Efti development in MBC	1	https://app.sharelinktechnologies.com/announcement/asx/72c93ee8b2c36cf666ea0c3bf8f866dc	Progress Report
2022-03-11 09:26:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/59fcab3eceef54e1349b09dac66e288e	Appendix 2A (Application for Quotation of Securities
2022-03-16 08:23:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/a14a5fc69fd1d4cc152de3668ab0391f	Change in substantial holding
2022-03-18 15:36:00	Japanese patent granted for LAG-3 antibody LAG525	1	https://app.sharelinktechnologies.com/announcement/asx/859892aa1ec22c3b8950aa30127cc13d	Progress Report
2022-03-18 16:18:00	Immutep to present Phase IIb breast cancer data at ESMO 2022	0	https://app.sharelinktechnologies.com/announcement/asx/dde143d416db2c042f0838caad3833b4	Progress Report Company Administration - Other
2022-03-24 08:19:00	Immutep announces publication of ELCC 2022 abstract	1	https://app.sharelinktechnologies.com/announcement/asx/f0f17323fab7806b18a36721790fd2e4	Progress Report
2022-03-30 08:24:00	Efti with Keytruda shows encouraging activity in lung cancer	1	https://app.sharelinktechnologies.com/announcement/asx/1f72ae91ee9d37ca42e4773fe4c86fdc	Progress Report
2022-04-08 08:20:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/f28728d88f1c5d9c2f554b1e2068570b	Change in substantial holding
2022-04-28 08:22:00	Immutep to announce new TACTI-002 data at ASCO 2022	1	https://app.sharelinktechnologies.com/announcement/asx/6a4018ea9077b4ee73d3af85c1cc5b88	Progress Report
2022-04-29 08:01:00	Quarterly Activities/Appendix 4C Cash Flow Report	1	https://app.sharelinktechnologies.com/announcement/asx/eb046cfd08aec55c17e993159ebe7bce	Commitments Test Entity - Third Quarter Report Commitments Test Entity - Third Quarter Activity Report
2022-05-04 18:54:00	New & significant data from AIPAC phase 2b trial in MBC	1	https://app.sharelinktechnologies.com/announcement/asx/975a52853b5f99d7a10b6f39de1a7736	Progress Report
2022-05-18 08:17:00	Leading Oncologists appointed to Clinical Advisory Board	0	https://app.sharelinktechnologies.com/announcement/asx/6a3553996eb9d9e634e0e7d6ef8e4716	Company Administration - Other
2022-05-20 08:22:00	Immutep to Present at Investor Conferences	0	https://app.sharelinktechnologies.com/announcement/asx/95dfd2154220d2fd26a7b2cde8e3212b	Company Administration - Other Web Casts
2022-05-24 17:28:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/60107de955fa3a8bf799dc41d173b819	Company Presentation
2022-05-27 07:34:00	Immutep announces publication of ASCO 2022 abstracts	1	https://app.sharelinktechnologies.com/announcement/asx/136e46eeebc2fabb936a003316e758a7	Progress Report
2022-06-02 08:17:00	Immutep webcast for TACTI-002 data presented at ASCO 2022	0	https://app.sharelinktechnologies.com/announcement/asx/8c2f91990c9b95c8620eb30b667feb03	Company Administration - Other Web Casts
2022-06-06 08:20:00	Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial	1	https://app.sharelinktechnologies.com/announcement/asx/beacec2d1caa8a77a7f7de450280b3d1	Progress Report
2022-06-06 09:04:00	Webcast slides for 1st line NSCLC data from TACTI-002 trial	1	https://app.sharelinktechnologies.com/announcement/asx/3f382e286c078a9bc7b763bb792ba094	Company Presentation Progress Report
2022-06-17 12:38:00	Immutep Investor Update	0	https://app.sharelinktechnologies.com/announcement/asx/f447e117c86343cbba172650c0ee8c57	Progress Report
2022-06-27 09:29:00	TACTI-002 lung cancer data to be presented at 2022 WCLC	0	https://app.sharelinktechnologies.com/announcement/asx/740c7d6cffde8f6a4d36acfb372090be	Company Administration - Other
2022-07-06 08:22:00	Immutep granted Japanese Patent for IMP761	1	https://app.sharelinktechnologies.com/announcement/asx/7d50a77fae09d41cef180925833c7f10	Progress Report
2022-07-14 17:25:00	Notification of cessation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/dadc1fb37494b82bffc75a36161221a4	Appendix 3H (Notification of cessation of securities)
2022-07-28 10:07:00	Quarterly Activities/Appendix 4C Cash Flow Report	1	https://app.sharelinktechnologies.com/announcement/asx/c304e265b515f6aa2a41816255c12960	Commitments Test Entity - Fourth Quarter Report Commitments Test Entity - Fourth Quarter Activity Report
2022-08-01 07:55:00	TACTI-002 2nd line lung cancer data presented at 2022 WCLC	1	https://app.sharelinktechnologies.com/announcement/asx/0c52e482e94f511fac55c5eb1a2d3e10	Progress Report
2022-08-30 09:43:00	Japanese Patent Grant for efti, soluble LAG-3 with anti-PD-1	1	https://app.sharelinktechnologies.com/announcement/asx/4a40aa14896f3ca1a66f0659a2d6e481	Progress Report
2022-08-31 17:35:00	Appendix 4E & 2022 Full Year Statutory Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/cb8e5397db04324fb48e7da8f6d31bf2	Annual Report Top 20 shareholders Preliminary Final Report Full Year Accounts Full Year Audit Review Full Year Directors' Statement Full Year Directors' Report
2022-09-06 09:21:00	New investigator-initiated ph2 trial in Soft Tissue Sarcoma	1	https://app.sharelinktechnologies.com/announcement/asx/d00c9f2272660883c307f038960e0f84	Progress Report
2022-09-13 08:14:00	Immutep Appoints LAG-3 Pioneer Dr Frederic Triebel to Board	0	https://app.sharelinktechnologies.com/announcement/asx/d326a505a1b1d86fc2309da914b0af61	Director Appointment/Resignation
2022-09-13 08:15:00	Initial Director's Interest Notice - Frederic Triebel	0	https://app.sharelinktechnologies.com/announcement/asx/357905d2026802d8270069f114d9bd55	Initial Director's Interest Notice
2022-09-14 08:14:00	Clinical Development Update for Eftilagimod Alpha	1	https://app.sharelinktechnologies.com/announcement/asx/931279e6b68a18b20b1dfcd79ae522c1	Progress Report
2022-09-21 09:09:00	2022 AGM & Key Dates	0	https://app.sharelinktechnologies.com/announcement/asx/e9c26029a04263697805cfc1a2cde699	Notice of Meeting - Other Company Administration - Other
2022-09-23 09:09:00	Immutep Receives A$2.7 million R&D French Tax Incentive	1	https://app.sharelinktechnologies.com/announcement/asx/0f22d53d2d155d3bfa4c5b4149c06d28	Periodic Reports - Other
2022-09-26 08:13:00	Immutep to Participate in Two Upcoming Investor Conferences	0	https://app.sharelinktechnologies.com/announcement/asx/408bc859f91089e959daa52d678f156d	Company Administration - Other Web Casts
2022-09-30 10:47:00	Becoming a substantial holder from AEF	0	https://app.sharelinktechnologies.com/announcement/asx/5dcc96f94f75e96cbc0993312ac314ae	Becoming a substantial holder
2022-10-03 11:49:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/abfe35d29a14505ccd900fe608d1c710	Appendix 2A (Application for Quotation of Securities
2022-10-04 09:53:00	Fast Track granted by US FDA for Efti in 1st line NSCLC	1	https://app.sharelinktechnologies.com/announcement/asx/e5627a615154229054965736d323bc69	Progress Report
2022-10-05 17:22:00	Change of Director's Interest Notice - F Triebel	0	https://app.sharelinktechnologies.com/announcement/asx/66c3c9397c2d64ab3596d8f6b155fbed	Change of Director's Interest Notice
2022-10-05 17:24:00	Change of Director's Interest Notice - P Meyers	0	https://app.sharelinktechnologies.com/announcement/asx/fdb61f0ed43ca098e94a1621ec370bc4	Change of Director's Interest Notice
2022-10-05 17:24:00	Change of Director's Interest Notice - M Voigt	0	https://app.sharelinktechnologies.com/announcement/asx/4d2c22bdf30cebebd711d495d70b245b	Change of Director's Interest Notice
2022-10-06 08:14:00	Abstracts accepted for Presentation at SITC 2022	1	https://app.sharelinktechnologies.com/announcement/asx/2b1d43b0872d9ad7b491ee7abb35d67f	Company Administration - Other
2022-10-06 11:07:00	Ceasing to be a substantial shareholder from AEF	0	https://app.sharelinktechnologies.com/announcement/asx/aa9a5304e2ef052830b4b5adcfaceb65	Ceasing to be a substantial holder
2022-10-13 09:11:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/efe6b311f5c66c46976623d9d140d15f	Appendix 2A (Application for Quotation of Securities
2022-10-18 08:08:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/180e5c65acdb7b237cfb8a200f0ef3f1	Change in substantial holding
2022-10-21 14:21:00	Annual Report to shareholders	0	https://app.sharelinktechnologies.com/announcement/asx/774e126aab696d4995ca2d552c1d51d1	Annual Report Top 20 shareholders Full Year Accounts Full Year Audit Review Full Year Directors' Statement Full Year Directors' Report
2022-10-21 14:26:00	Appendix 4G and Corporate Governance Statement	0	https://app.sharelinktechnologies.com/announcement/asx/9a2a14c0e21f855243443bb5ae401380	Corporate Governance Takeover - Appendix 4G
2022-10-21 14:37:00	Notice of Annual General Meeting/Proxy Form	0	https://app.sharelinktechnologies.com/announcement/asx/793b723bb609d43c3504a86072718882	Notice of Annual General Meeting Proxy Form Letter to Shareholders
2022-10-25 10:49:00	Quarterly Activities/Appendix 4C Cash Flow Report	1	https://app.sharelinktechnologies.com/announcement/asx/187d7cc57e9dab8627ae5b80cdf18560	Commitments Test Entity - First Quarter Report Commitments Test Entity - First Quarter Activity Report
2022-10-26 09:36:00	Independent DMC recommends to continue TACTI-003 as planned	1	https://app.sharelinktechnologies.com/announcement/asx/224ac9ff944310f6193d97dcc87886d4	Progress Report
2022-10-31 16:07:00	Change of Registry Address	0	https://app.sharelinktechnologies.com/announcement/asx/a01e374363e5cc65ca3af1b3a1f5536b	Details of Share Registry address
2022-11-01 07:38:00	Annual Report filed on Form 20-F with SEC	0	https://app.sharelinktechnologies.com/announcement/asx/194814f898dc5107e4729ddf5f593d30	Annual Report
2022-11-02 10:28:00	Immutep to Participate in Two Upcoming Investor Conferences	0	https://app.sharelinktechnologies.com/announcement/asx/da3a6319de72a581396f4dedcdba6a75	Web Casts
2022-11-02 12:45:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/5fef6efd1493533ce144bd74634b5a6a	Company Presentation
2022-11-03 08:33:00	Late Breaking Abstract accepted for SITC Oral Presentation	1	https://app.sharelinktechnologies.com/announcement/asx/ccf46a48c4a68cbbca02dc55fadd2581	Progress Report
2022-11-04 09:08:00	Abstract for Efti selected for SITC 2022 Press Conference	0	https://app.sharelinktechnologies.com/announcement/asx/5221cdf354a31c13267296ee686a8c94	Progress Report Web Casts
2022-11-09 15:33:00	New Patents Granted in Japan and South Korea for Efti	1	https://app.sharelinktechnologies.com/announcement/asx/068fedc0318485784684efa19c01a74b	Progress Report
2022-11-11 08:16:00	Immutep Webcast to discuss clinical data presented at SITC	1	https://app.sharelinktechnologies.com/announcement/asx/734051b89c65d3a04bca9d512b7959ba	Company Presentation
2022-11-11 08:16:00	TACTI-002 data presented at SITC for Efti in 1st line NSCLC	1	https://app.sharelinktechnologies.com/announcement/asx/1653d107c6f9fe9dd696cb9ab3d444a6	Progress Report Company Administration - Other
2022-11-11 08:16:00	INSIGHT-003 triple combination data presented at SITC 2022	1	https://app.sharelinktechnologies.com/announcement/asx/87043c2acccb51885429641907d5f958	Progress Report Company Administration - Other
2022-11-14 09:18:00	Immutep receives A$1 million R&D Tax Incentive	1	https://app.sharelinktechnologies.com/announcement/asx/9f8100325350b45d8cbd7be70dd7521d	Periodic Reports - Other Company Administration - Other
2022-11-17 10:58:00	Immutep Investor Update	0	https://app.sharelinktechnologies.com/announcement/asx/adc9bce723c89ccbbe5df517e551349c	Periodic Reports - Other Progress Report
2022-11-23 08:18:00	Immutep AGM 2022 - CEO's Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/709b70e60c0f21511d5a43735c607919	Company Presentation Chairman's Address to Shareholders
2022-11-23 08:18:00	Immutep AGM 2022 - Chairman's Address	0	https://app.sharelinktechnologies.com/announcement/asx/75157dc9a067bf299a342b0e443223c1	Chairman's Address to Shareholders
2022-11-23 13:01:00	Results of Meeting	0	https://app.sharelinktechnologies.com/announcement/asx/447245742f18600a4fc3497aad43744b	Results of Meeting
2022-11-29 08:14:00	Immutep enters 2nd collaboration with Pfizer and Merck KGaA	1	https://app.sharelinktechnologies.com/announcement/asx/469a79dcada667aa3934b29b4108ae7a	Progress Report
2022-12-06 08:59:00	GMP Manufacturing Process Developed for IMP761 LAG-3 Agonist	1	https://app.sharelinktechnologies.com/announcement/asx/d4aa1386240d2cf4e7200d271fb29c6e	Progress Report
2022-12-08 08:16:00	Commercial Scale in Manufacturing of Efti Achieved	1	https://app.sharelinktechnologies.com/announcement/asx/eea35e07c34d640e588c7f91a26377b6	Progress Report
2022-12-15 11:09:00	Proposed issue of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/adf08ecc0d3ed5ffd9018ebb3d20fddd	Appendix 3B
2022-12-16 15:25:00	Notification regarding unquoted securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/3fd9d44b6cf9cff9ab963e222384b06a	Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2022-12-16 15:26:00	Notification regarding unquoted securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/a6bf3d2ed8cd838caf0f585ed68a0069	Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2022-12-21 12:08:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/bbabb563bb8bea25d775dce7836abdb6	Appendix 2A (Application for Quotation of Securities
2022-12-22 15:54:00	Change of Director's Interest Notice - R Howard	0	https://app.sharelinktechnologies.com/announcement/asx/605d8b4d19d316686dda8ef1b9783704	Change of Director's Interest Notice
2022-12-22 15:56:00	Change of Director's Interest Notice - P Meyers	0	https://app.sharelinktechnologies.com/announcement/asx/9c82a5d7553194f767d6ae5fb6879602	Change of Director's Interest Notice
2022-12-22 15:58:00	Change of Director's Interest Notice L Turnbull	0	https://app.sharelinktechnologies.com/announcement/asx/cef5cfb34bdf5ff6deec73d9e5687a2f	Change of Director's Interest Notice
2022-12-23 13:00:00	Update on MBC trial design following successful FDA meeting	1	https://app.sharelinktechnologies.com/announcement/asx/9db9c27a2ba4d09307b52a86665cac74	Progress Report
2023-01-04 08:19:00	TACTI-003 trial 50% enrolment milestone has been achieved	1	https://app.sharelinktechnologies.com/announcement/asx/668470b9f1cf26f3dc37cbd3954715cc	Progress Report
2023-01-06 16:13:00	Notification of cessation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/1d99c58a3f496597e6415cea9ed46fed	Appendix 3H (Notification of cessation of securities)
2023-01-30 08:34:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/0f91b6f79db7898a58f8fb56c5e27494	Commitments Test Entity - Second Quarter Report Commitments Test Entity - Second Quarter Activity Report
2023-02-06 08:48:00	Enrolment Target Reached for INSIGHT-003 Trial in NSCLC	1	https://app.sharelinktechnologies.com/announcement/asx/21bd1a79cad8cf58e978457fd6c2e8a4	Progress Report
2023-02-24 18:57:00	Half Yearly Report and Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/abb18f77ea7d68ab05254b356fdb17af	Half Yearly Report Half Year Audit Review Half Year Directors' Statement Half Year Accounts Half Year Directors' Report
2023-03-14 08:11:00	Initiation of Ph 2/3 Trial for Metastatic Breast Cancer	1	https://app.sharelinktechnologies.com/announcement/asx/8402efcbece01468b76b0fa4005a14c5	Progress Report
2023-03-23 11:22:00	Abstract accepted for ESMO's European Lung Cancer Congress	0	https://app.sharelinktechnologies.com/announcement/asx/9dc3e15abdf5451fbbb39a3b8c259f18	Company Administration - Other Web Casts
2023-03-30 09:57:00	Expansion of INSIGHT-003 trial for Efti in 1st Line NSCLC	1	https://app.sharelinktechnologies.com/announcement/asx/403c4a19d46fb25960f615878663d2bd	Progress Report
2023-03-31 08:15:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/497298999b8a2e5b45dc08f02f90e629	Change in substantial holding
2023-03-31 17:47:00	Positive Final Data in 2nd Line Metastatic NSCLC Patients	1	https://app.sharelinktechnologies.com/announcement/asx/f988c1e15601a8fa056e52c10ade13d2	Progress Report
2023-04-11 08:38:00	Immutep Announces Changes to the Board	0	https://app.sharelinktechnologies.com/announcement/asx/46097d2d86ba1badb693265c3bc04cba	Director Appointment/Resignation
2023-04-11 08:42:00	Appendix 3X - Lis Boyce	0	https://app.sharelinktechnologies.com/announcement/asx/927c8fd20ba87df1e2ac1466ee308755	Initial Director's Interest Notice
2023-04-11 09:11:00	Appendix 3Z - Lucy Turnbull	0	https://app.sharelinktechnologies.com/announcement/asx/8318651d0edf6157326c8646f909e1b1	Final Director's Interest Notice
2023-04-11 09:59:00	Notification of cessation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/6e5b72d8925d912a07a823f4ec05d9ce	Appendix 3H (Notification of cessation of securities)
2023-04-17 08:24:00	Initiation of Phase 2 Trial for Efti in Soft Tissue Sarcoma	1	https://app.sharelinktechnologies.com/announcement/asx/1169ec05c23516d2348ed7a5c455fbd9	Progress Report
2023-04-18 10:22:00	Response to ASX Aware Query	1	https://app.sharelinktechnologies.com/announcement/asx/1c994fac032e56f004e27e041360aa5a	Response to ASX Query
2023-04-26 08:46:00	Immutep appoints Dr Florian Vogl as Chief Medical Officer	0	https://app.sharelinktechnologies.com/announcement/asx/09b704e9bd2ace64409e2df725ede205	Company Administration - Other
2023-04-27 08:02:00	Immutep to announce new TACTI-002 data at ASCO 2023	1	https://app.sharelinktechnologies.com/announcement/asx/5db2283bd902adfc3d57f592caac9c98	Progress Report
2023-04-27 08:04:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/48a3189ce9758eceaad39da2d354f1a2	Commitments Test Entity - Third Quarter Report Commitments Test Entity - Third Quarter Activity Report
2023-05-01 08:12:00	Approval to start Efti & Bavencio trial in urothelial cancer	1	https://app.sharelinktechnologies.com/announcement/asx/aeed2dc1f96c6bd870149e62922a7742	Progress Report
2023-05-02 08:18:00	Change of Director's Interest Notice - R Howard	0	https://app.sharelinktechnologies.com/announcement/asx/66f4a35afb4de426f69f05f55c646c04	Change of Director's Interest Notice
2023-05-16 08:18:00	FDA supportive of Efti registrational trial in lung cancer	1	https://app.sharelinktechnologies.com/announcement/asx/2a7448991abd55a4cd660911fe81de6e	Progress Report
2023-05-17 09:02:00	Excellent initial Overall Survival Benefit in 1st line NSCLC	1	https://app.sharelinktechnologies.com/announcement/asx/05407d5ff00808c133d3cbd464ba6230	Progress Report
2023-05-24 09:01:00	Promising New Data in 1st line NSCLC from INSIGHT-003 Trial	1	https://app.sharelinktechnologies.com/announcement/asx/14e57c817bf8a3138d1bfb8defe72c67	Progress Report
2023-05-25 08:19:00	1st patient dosed in AIPAC-003 ph2/3 breast cancer trial	1	https://app.sharelinktechnologies.com/announcement/asx/e33ba23f3e92b84bb780e4e25a99ff02	Progress Report
2023-05-26 08:24:00	Publication of Abstracts for ASCO 2023 Annual Meeting	1	https://app.sharelinktechnologies.com/announcement/asx/f0d78fd5e831c528ed67cc7d1cbe2827	Progress Report - Other
2023-05-29 08:20:00	Charles River Laboratories to run IMP761 Toxicology Study	1	https://app.sharelinktechnologies.com/announcement/asx/7f1929f37eb0b32c87e76e3ef0bdbe70	Progress Report
2023-05-31 09:21:00	Trading Halt	1	https://app.sharelinktechnologies.com/announcement/asx/055d8400a23745a1a5c5cebf379c5a6c	Trading Halt
2023-05-31 09:38:00	A$80 million fully underwritten equity raising	1	https://app.sharelinktechnologies.com/announcement/asx/1621e575fb452cff0a043f8abadd02fa	Placement Non-Renounceable Issue Issued Capital - Other
2023-05-31 10:10:00	Immutep Capital Raising Presentation	1	https://app.sharelinktechnologies.com/announcement/asx/ed51d503bf41f37d1b9b19cbb0c8fa69	Company Presentation
2023-05-31 10:25:00	Proposed issue of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/ee1c887f98c0a336a65d4c7e8bd2328b	Appendix 3B
2023-05-31 10:47:00	Cleansing Notice	0	https://app.sharelinktechnologies.com/announcement/asx/68fa8c1531978aa5eb7069321439442a	Cleansing Notice
2023-06-01 08:22:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/d6a58fc9a9ee5103744f112d7dd1fa3e	Change in substantial holding
2023-06-02 09:02:00	Immutep completes institutional pro-rata offer & placement	1	https://app.sharelinktechnologies.com/announcement/asx/0073c0db2a6071e0e66713a3603f7b0d	Placement Non-Renounceable Issue Trading Halt Lifted
2023-06-05 08:41:00	Positive final data in 2nd line head and neck cancer at ASCO	0	https://app.sharelinktechnologies.com/announcement/asx/39832be51ce0be052165bb18a77fa66a	Progress Report
2023-06-06 08:13:00	Immutep retail entitlement offer booklet	0	https://app.sharelinktechnologies.com/announcement/asx/5d26c1365f2a14e7ea7923ef9e5e16f4	Non-Renounceable Issue Disclosure Document
2023-06-06 08:36:00	Immutep letter to ineligible shareholders	0	https://app.sharelinktechnologies.com/announcement/asx/100bb699dfa1f790212e060739275820	Non-Renounceable Issue Letter to Shareholders
2023-06-08 10:20:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/aff1507139a9344a00bfabde4c6e564e	Appendix 2A (Application for Quotation of Securities
2023-06-08 10:51:00	Cleansing Notice	0	https://app.sharelinktechnologies.com/announcement/asx/9339ba3880470d7aa64531d15aba5a28	Cleansing Notice
2023-06-09 14:58:00	Becoming a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/295c686eddefbe5aafc6281e3ed6ddfb	Becoming a substantial holder
2023-06-13 08:10:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/13ca429fa75f8b59d856acaf9dc3dbc0	Change in substantial holding
2023-06-13 18:47:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/68188d4682aa9e7660f9ecab8d73a101	Change in substantial holding
2023-06-16 16:53:00	Change in substantial holding from IFL	0	https://app.sharelinktechnologies.com/announcement/asx/79bf4f1cd7375951088fbaef7411f7dc	Change in substantial holding
2023-06-20 14:43:00	Immutep granted US patent for IMP761 agonist LAG-3 antibody	1	https://app.sharelinktechnologies.com/announcement/asx/d9bc116a6c7eb4acf4c158ca37f38629	Progress Report
2023-06-27 08:16:00	Immutep completes underwritten retail entitlement offer	1	https://app.sharelinktechnologies.com/announcement/asx/513dbcde80c2383fefbd0980415e25cc	Placement Non-Renounceable Issue
2023-06-27 14:37:00	US patent granted for Efti with PD-1 pathway inhibitor	1	https://app.sharelinktechnologies.com/announcement/asx/44c513ba7d296a08c24228e2bba8a6a6	Progress Report
2023-06-29 10:09:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/93196806a8669d46342f952e63ef2cb9	Appendix 2A (Application for Quotation of Securities
2023-07-28 08:50:00	1st Patient Dosed in Phase 2 Soft Tissue Sarcoma Trial	1	https://app.sharelinktechnologies.com/announcement/asx/90d484c14aaeb100c5ce46b35263fa02	Progress Report
2023-07-31 09:07:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/c09b4d888a2da0ed984c8f154fb2ec9e	Commitments Test Entity - Second Quarter Report Commitments Test Entity - Second Quarter Activity Report
2023-07-31 17:16:00	Efti clinical data to be presented at ESMO Congress 2023	0	https://app.sharelinktechnologies.com/announcement/asx/6c3e2f3fa9de7678462e0bd82e50c4e5	Progress Report
2023-08-01 12:10:00	Immutep receives positive scientific advice from EMA	1	https://app.sharelinktechnologies.com/announcement/asx/c42914b55a383ec9ca0f4d2db19f7f06	Progress Report
2023-08-18 09:04:00	Immutep Investor Update	0	https://app.sharelinktechnologies.com/announcement/asx/45f3698fcfea504cc15f4072f11c0930	Periodic Reports - Other Letter to Shareholders
2023-08-30 09:38:00	Appendix 4E & 2023 Full Year Statutory Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/80c2aa83e5655589e4f040980ec0e48c	Annual Report Top 20 shareholders Preliminary Final Report Full Year Accounts Full Year Audit Review Full Year Directors' Statement Full Year Directors' Report
2023-09-06 08:52:00	Immutep to Participate in September Investor Conferences	0	https://app.sharelinktechnologies.com/announcement/asx/860ca7fe9a6416a9f6b90b5514fe6f7d	Company Administration - Other
2023-09-08 11:08:00	2023 AGM & Key Dates	0	https://app.sharelinktechnologies.com/announcement/asx/e15e6a967f3b05064b805f27fe538895	Proxy Form Notice of Meeting - Other
2023-09-21 08:14:00	Commercial Scale Manufacturing of Efti for Clinical Trials	1	https://app.sharelinktechnologies.com/announcement/asx/57982d4fdccf272dc696b2816eec504c	Progress Report
2023-09-22 13:17:00	Annual Report to shareholders	0	https://app.sharelinktechnologies.com/announcement/asx/73fada4edfc6546b930b5b2eb64fcaed	Annual Report Top 20 shareholders Full Year Accounts Full Year Audit Review Full Year Directors' Statement Full Year Directors' Report
2023-09-22 13:22:00	Appendix 4G and Corporate Governance Statement	0	https://app.sharelinktechnologies.com/announcement/asx/c1a4ff93f99b1476ecfd5f4108f48da2	Corporate Governance Takeover - Appendix 4G
2023-09-22 13:36:00	Notice of Annual General Meeting/Proxy Form	0	https://app.sharelinktechnologies.com/announcement/asx/06b81ca76be8ac5421b6b82b79d09ab9	Notice of Annual General Meeting Proxy Form Web Casts Letter to Shareholders
2023-10-03 09:12:00	Immutep announces acceptance of abstract for SITC 2023	0	https://app.sharelinktechnologies.com/announcement/asx/d3f2a52daf223fe96208378d2a6a0c3f	Company Administration - Other
2023-10-03 10:29:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/591d4701a6b797f9941c2279d9637ee4	Appendix 2A (Application for Quotation of Securities
2023-10-05 13:23:00	Change of Director's Interest Notice - Pete Meyers	0	https://app.sharelinktechnologies.com/announcement/asx/c3aacaee066be1edeed40467be4f6f81	Change of Director's Interest Notice
2023-10-16 09:10:00	Immutep announces publication of ESMO 2023 abstracts	1	https://app.sharelinktechnologies.com/announcement/asx/3396c0530eb1207c55a3332429e842bf	Progress Report
2023-10-23 07:48:00	Excellent Overall Survival in Non-Small Cell Lung Cancer	1	https://app.sharelinktechnologies.com/announcement/asx/98607cbd225004836510341598cf973e	Progress Report Web Casts
2023-10-23 07:48:00	Webcast slides for new Efti clinical data in 1st line NSCLC	1	https://app.sharelinktechnologies.com/announcement/asx/a6c7faf314cb1314b2234573cecee4f5	Company Presentation
2023-10-24 08:12:00	Immutep reports promising data from INSIGHT-003 trial	1	https://app.sharelinktechnologies.com/announcement/asx/3ea234adbf23ba7bd2b7ce7f1e5b9170	Progress Report
2023-10-24 08:13:00	Immutep AGM 2023 - CEO's Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/d94b7af4d9055e5ef643f740c5345429	Company Presentation Chairman's Address to Shareholders
2023-10-24 08:13:00	Immutep AGM 2023 - Chairman's Address	0	https://app.sharelinktechnologies.com/announcement/asx/f5bdb9365b92dececa7fa6af4c8008bc	Chairman's Address to Shareholders
2023-10-24 11:52:00	Results of Meeting	0	https://app.sharelinktechnologies.com/announcement/asx/e7879ac7785043e91e297cff0d6de6df	Results of Meeting
2023-10-25 10:53:00	Immutep receives Australian R&D Tax Incentive	0	https://app.sharelinktechnologies.com/announcement/asx/1710814483ea0dc5c2564f8ecc237e28	Periodic Reports - Other Company Administration - Other
2023-10-25 11:01:00	Annual Report filed on Form 20-F with SEC	0	https://app.sharelinktechnologies.com/announcement/asx/28ad8bc538a1da0f480ce873833e227f	Annual Report
2023-10-31 08:43:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/cd609b7441de631b08ee6db0e761a13b	Commitments Test Entity - First Quarter Report Commitments Test Entity - First Quarter Activity Report
2023-11-02 08:28:00	Immutep to Participate in November Investor Events	0	https://app.sharelinktechnologies.com/announcement/asx/80e2f3a055fc3edf17ab0f7e49733fae	Company Administration - Other
2023-11-03 08:16:00	New Biomarker Data from TACTI-002 trial in 1st line NSCLC	1	https://app.sharelinktechnologies.com/announcement/asx/f907c96ffd82ecf194883536e9abe6d4	Progress Report
2023-11-06 08:29:00	Lead-in phase completed for ph2/3 trial in Breast Cancer	1	https://app.sharelinktechnologies.com/announcement/asx/4098989f68f6f490afb057f9da49026a	Progress Report
2023-11-09 08:21:00	Immutep Completes Enrolment for TACTI-003 Phase IIb Trial	1	https://app.sharelinktechnologies.com/announcement/asx/576b1c53d52bbcdd3244d3022634a357	Progress Report
2023-11-22 10:41:00	Proposed issue of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/5d0ccab639ec1f9f443f9ca214216464	Appendix 3B
2023-11-22 12:31:00	Immutep Announces Site Expansion for INSIGHT-003 Trial	0	https://app.sharelinktechnologies.com/announcement/asx/5443b598e7c1fb41800ce53f0ba4797f	Progress Report
2023-11-23 09:26:00	Notification regarding unquoted securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/84a125e38b27de392d3977e099651919	Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2023-11-23 17:24:00	Change of Director's Interest Notice - L Boyce	0	https://app.sharelinktechnologies.com/announcement/asx/189a9f0714ad22cc0d7ab915a88adab7	Change of Director's Interest Notice
2023-11-23 17:24:00	Change of Director's Interest Notice - R Howard	0	https://app.sharelinktechnologies.com/announcement/asx/0339b3fe5bb74822315b203955281ad4	Change of Director's Interest Notice
2023-12-07 08:16:00	Immutep receives A$2.6 million French R&D Tax Incentive	1	https://app.sharelinktechnologies.com/announcement/asx/758d74b12957ffc198b17a2cc5bbba34	Progress Report Company Administration - Other
2023-12-21 08:23:00	PEI provides constructive feedback for ph3 lung cancer trial	1	https://app.sharelinktechnologies.com/announcement/asx/0f8347c5dbd5ad072f6341ca8b08bb84	Progress Report
2023-12-22 15:16:00	Change of Registered Office Address	0	https://app.sharelinktechnologies.com/announcement/asx/879cf786bec259bf890f5a016b873590	Details of Registered office address
2024-01-04 09:13:00	First Patient Dosed in Urothelial Cancer INSIGHT-005 Trial	0	https://app.sharelinktechnologies.com/announcement/asx/0681f63cab07a4c3339c60fc213712bf	Progress Report
2024-01-08 08:22:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/8eab8e68671a37661d3c8cedf1940b80	Company Presentation
2024-01-15 17:03:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/dddc7997dcc4a85236bde28e098ab7fa	Change in substantial holding
2024-01-30 08:32:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/f974b1158e6e9fe43fab9a64b21cf036	Commitments Test Entity - Second Quarter Report Commitments Test Entity - Second Quarter Activity Report
2024-01-31 19:31:00	Notification regarding unquoted securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/49b6c543ff2139acc7d4c3e029ab5a84	Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2024-02-14 09:12:00	Appointment of Non-Executive Director	0	https://app.sharelinktechnologies.com/announcement/asx/c5bf709600c2755d526d0876d9d4cced	Director Appointment/Resignation
2024-02-14 10:20:00	Appendix 3X - Anne Anderson	0	https://app.sharelinktechnologies.com/announcement/asx/b88c65f565f3f9ed4d4bbde429e16571	Initial Director's Interest Notice
2024-02-14 13:05:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/8c8900ee77c1a7169f41d4ad4edf0845	Ceasing to be a substantial holder
2024-02-15 16:45:00	Becoming a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/76ab17c47eabb7c014e14b4f46740c48	Becoming a substantial holder
2024-02-20 16:46:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/08a43b9d275c2c087e56e061fead178c	Change in substantial holding
2024-02-21 16:55:00	Immutep Investor Update	0	https://app.sharelinktechnologies.com/announcement/asx/1dbd4ec3cc065acdb862bfcfcfeb230e	Periodic Reports - Other Letter to Shareholders
2024-02-22 18:14:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/a6b56aa2a36b5858d438262606935a3f	Change in substantial holding
2024-02-26 16:47:00	Becoming a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/0e15d7a4803eb2318752c4ec8deb3e5e	Becoming a substantial holder
2024-02-28 09:39:00	Half Yearly Report and Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/923355c17b6516dd53465405abacbd63	Half Yearly Report Half Year Audit Review Half Year Directors' Statement Half Year Accounts Half Year Directors' Report
2024-03-05 12:34:00	First Clinical Data announced from 90mg Dosing of Efti	1	https://app.sharelinktechnologies.com/announcement/asx/e7eb8029b775cc6ef3029596453570a0	Progress Report
2024-03-08 16:27:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/5072a2741ccc5e921edc61a6523422b6	Ceasing to be a substantial holder
2024-04-11 18:30:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/4a319c100c2afa915652dcdaae237244	Ceasing to be a substantial holder
2024-04-17 09:10:00	Positive Feedback received from Spanish Medicines Agency	0	https://app.sharelinktechnologies.com/announcement/asx/d43894001dafa767ff0f66e980d8cca2	Progress Report
2024-04-18 09:36:00	CHDR to conduct first-in-human phase 1 trial of IMP761	1	https://app.sharelinktechnologies.com/announcement/asx/a98578c19ebb71f188e1e45a50925906	Progress Report
2024-04-24 08:40:00	Positive preliminary topline results from TACTI-003 Cohort B	1	https://app.sharelinktechnologies.com/announcement/asx/b2451fe39828d6a3bc21477964b57aff	Progress Report
2024-04-29 08:18:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/35d064011d471f1cca85165ef4aaee1a	Commitments Test Entity - Third Quarter Report Commitments Test Entity - Third Quarter Activity Report
2024-05-02 09:29:00	Positive initial data in phase 2 Soft Tissue Sarcoma trial	1	https://app.sharelinktechnologies.com/announcement/asx/24f49f8204f4760123e9087c622c4511	Progress Report
2024-05-15 18:01:00	AIPAC-003 safety lead-in data presented at ESMO Breast 2024	1	https://app.sharelinktechnologies.com/announcement/asx/9eb3278d9e3ac507acecc898dd73301e	Progress Report
2024-06-03 08:51:00	Trading Halt	1	https://app.sharelinktechnologies.com/announcement/asx/43f1ca7e5e47afbb3884635083c1902e	Trading Halt
2024-06-03 09:14:00	A$100 million fully underwritten equity raising	1	https://app.sharelinktechnologies.com/announcement/asx/26136f6e9e3d0db0120f09828ba9abb9	Placement Non-Renounceable Issue
2024-06-03 09:19:00	Immutep Capital Raising Presentation	1	https://app.sharelinktechnologies.com/announcement/asx/799ffde1268524e73b1f875e31347238	Company Presentation
2024-06-03 09:28:00	Proposed issue of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/95995a9bf07a9771fcdb4c8f820c1910	Appendix 3B
2024-06-03 09:41:00	Immutep announces Ph 3 clinical trial collaboration with MSD	1	https://app.sharelinktechnologies.com/announcement/asx/fe0d6f7ca0f0591ba6df1946be184838	Progress Report
2024-06-03 10:00:00	Cleansing Notice	0	https://app.sharelinktechnologies.com/announcement/asx/694b4b2625b95c2b2fd0acde10dec370	Cleansing Notice
2024-06-05 09:11:00	Immutep completes institutional pro-rata offer & placement	1	https://app.sharelinktechnologies.com/announcement/asx/3ff9d50f9b9307e6bf606cccefcaf8f2	Placement Non-Renounceable Issue Trading Halt Lifted
2024-06-07 12:53:00	Immutep retail entitlement offer booklet	0	https://app.sharelinktechnologies.com/announcement/asx/088affa7bb319d3fcff0726c9469c5ef	Non-Renounceable Issue Disclosure Document
2024-06-07 13:02:00	Immutep letter to ineligible shareholders	0	https://app.sharelinktechnologies.com/announcement/asx/ee732df5d1565b5a4475b6225170d9a3	Non-Renounceable Issue Letter to Shareholders
2024-06-12 09:30:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/818307d8f0d9ff4155f9c5be6b140e28	Appendix 2A (Application for Quotation of Securities
2024-06-12 10:10:00	Cleansing Notice	0	https://app.sharelinktechnologies.com/announcement/asx/94830e3d827e21f8c3e4c39f6fa048b1	Cleansing Notice
2024-06-14 08:19:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/9cc703c46fe703f60d717ab0ac181af2	Change in substantial holding
2024-06-14 16:49:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/99ce5e7eff1927f5e3bdc9e29739693a	Change in substantial holding
2024-06-18 12:16:00	Change in substantial holding from IFL	0	https://app.sharelinktechnologies.com/announcement/asx/1502c85a799a8961d3f3b9ccf8068cdd	Change in substantial holding
2024-06-24 13:53:00	Immutep completes underwritten retail entitlement offer	1	https://app.sharelinktechnologies.com/announcement/asx/9babeb08b25b0f91ba73adb9a30b2b22	Non-Renounceable Issue Issued Capital - Other
2024-06-25 08:16:00	Immutep signs agreement for anti-LAG-3 small molecules	0	https://app.sharelinktechnologies.com/announcement/asx/6d9a36a3f6f55e5f4bc8e20adab8ca98	Progress Report
2024-06-25 08:59:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/b1de55ba56e3ebf02d8f12ced083102e	Appendix 2A (Application for Quotation of Securities
2024-06-27 08:09:00	Positive topline results from ph2b in head & neck cancer	1	https://app.sharelinktechnologies.com/announcement/asx/01c5467c4a7bfb7ff699b32dd8adcd34	Progress Report
2024-06-27 08:31:00	Webcast slides for new Efti clinical data in 1st line HNSCC	1	https://app.sharelinktechnologies.com/announcement/asx/b235b06f7415ed3bc29fec34729a0282	Company Presentation
2024-07-03 08:33:00	Details for Immutep Webcast & ESMO Virtual Plenary Session	0	https://app.sharelinktechnologies.com/announcement/asx/85d22153acabcc162a340f52533bea2a	Web Casts
2024-07-04 08:16:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/963ab987dafaac2b364ba94cb2aa75ca	Change in substantial holding
2024-07-12 08:26:00	Webcast to discuss data presented at ESMO Plenary Session	1	https://app.sharelinktechnologies.com/announcement/asx/95e5ec28b393fecd37252210d1457b4b	Company Presentation Web Casts
2024-07-12 08:26:00	Positive results in TACTI-003 for 1L HNSCC cohort B patients	1	https://app.sharelinktechnologies.com/announcement/asx/33fe812d78c0112b1d0aaf1dfc7178ee	Progress Report Web Casts
2024-07-12 15:51:00	Becoming a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/30fa848918c13be9b89893ce8a1ff451	Becoming a substantial holder
2024-07-17 08:48:00	Regulatory Clearance received for Phase 1 trial of IMP761	1	https://app.sharelinktechnologies.com/announcement/asx/9e31eb4c7a341fe1f7927a832d68b447	Progress Report
2024-07-22 08:12:00	Successful Meeting with FDA on Phase III Design in NSCLC	1	https://app.sharelinktechnologies.com/announcement/asx/51086c5abb8fdd3bbf98f9457a22db26	Progress Report
2024-07-26 16:43:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/a849231eebbaad415c2ef36c7ff64bbb	Change in substantial holding
2024-07-31 09:28:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/406bc9ab12b0345399ba44d1c2e9b18b	Commitments Test Entity - Fourth Quarter Report Commitments Test Entity - Fourth Quarter Activity Report
2024-08-07 09:12:00	Immutep to Participate in Upcoming Investor Conferences	0	https://app.sharelinktechnologies.com/announcement/asx/3b13202a9df85eddd6e654549620dee1	Web Casts
2024-08-14 08:19:00	First Participant Dosed in Phase I Study of IMP761	1	https://app.sharelinktechnologies.com/announcement/asx/ba56fa85a413ef34be18be0caf36c07b	Progress Report
2024-08-20 09:50:00	TACTI-003 data selected for oral presentation at ESMO 2024	1	https://app.sharelinktechnologies.com/announcement/asx/a1f1e97d7768b2df3b5095136a27e247	Company Administration - Other
2024-08-21 09:26:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/6b7f69925dc47162548e2e3090f39b97	Company Presentation
2024-08-30 09:55:00	Appendix 4E & 2024 Full Year Statutory Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/c1a70b0380c9baa0c19e7307bc018f79	Annual Report Top 20 shareholders Preliminary Final Report Full Year Accounts Full Year Audit Review Full Year Directors' Statement Full Year Directors' Report
2024-09-06 17:10:00	S&P DJI Announces September 2024 Quarterly Rebalance	1	https://app.sharelinktechnologies.com/announcement/asx/b2acbafea79ac239216416f7e5149c6d	Standard and Poor's Announcement
2024-09-12 18:55:00	Becoming a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/11e4a6110cf84c2fb0e667ecd87d28f3	Becoming a substantial holder
2024-09-16 08:30:00	New Positive Efficacy Data for Efti in Head and Neck Cancer	1	https://app.sharelinktechnologies.com/announcement/asx/b3cf6428a84d82cbe9fd27938def2980	Progress Report
2024-09-18 08:32:00	Data to be presented from Ph II trial in Soft Tissue Sarcoma	0	https://app.sharelinktechnologies.com/announcement/asx/268871fa449ec5591e82e359e3fb83ac	Progress Report
2024-09-19 09:55:00	Change of Director's Interest Notice - M Voigt	0	https://app.sharelinktechnologies.com/announcement/asx/bc5e695552849b20005814f2d7cd7a43	Change of Director's Interest Notice
2024-09-24 08:29:00	Immutep receives A$3.6 million French R&D Tax Incentive	1	https://app.sharelinktechnologies.com/announcement/asx/65e630625229a1cb56a832773d7bef29	Periodic Reports - Other
2024-09-24 16:39:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/0c1d3aeca4e557938ad363d3fd17f259	Change in substantial holding
2024-09-25 15:29:00	Change in substantial holding from IFL	0	https://app.sharelinktechnologies.com/announcement/asx/28ae92a0ab102c34464716789266900f	Change in substantial holding
2024-09-26 19:00:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/6997df248ad9307896de112c512c065d	Ceasing to be a substantial holder
2024-10-01 12:42:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/f4464c6201e29bbdead03db73241e3dc	Appendix 2A (Application for Quotation of Securities
2024-10-02 14:47:00	Change of Director's Interest Notice - Pete Meyers	0	https://app.sharelinktechnologies.com/announcement/asx/92bd294e79e2513466f54ac8fa5549f0	Change of Director's Interest Notice
2024-10-03 09:50:00	Enrolment for Ph II AIPAC-003 Breast Cancer Trial Completed	1	https://app.sharelinktechnologies.com/announcement/asx/7eac6a291d939a8c2cf3e45da7c101af	Progress Report
2024-10-04 16:57:00	Resignation of Non-executive Director	0	https://app.sharelinktechnologies.com/announcement/asx/ec93076537735b3cc04465e90c5b1603	Director Appointment/Resignation
2024-10-10 11:38:00	2024 AGM & Key Dates	0	https://app.sharelinktechnologies.com/announcement/asx/950ab011da15330c28687616bd6a47b1	Notice of Meeting - Other
2024-10-14 16:07:00	Appendix 3Z - Anne Anderson	0	https://app.sharelinktechnologies.com/announcement/asx/1a74e25e4ddd0b836a4db6270160ccd3	Final Director's Interest Notice
2024-10-17 10:29:00	IMP761 Progresses to Dose Escalation Portion of Ph1 Trial	0	https://app.sharelinktechnologies.com/announcement/asx/e88f1f7aceb1d947da7edb00e06860d3	Progress Report
2024-10-17 19:48:00	Becoming a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/088966e83bf58b997c43a41bf737c086	Becoming a substantial holder
2024-10-18 08:21:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/8478f4145dae9197f000618db7556f51	Change in substantial holding
2024-10-21 19:32:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/0eb2003fdc2d89a77e2e3556f07eed98	Ceasing to be a substantial holder
2024-10-22 12:03:00	Annual Report to shareholders	0	https://app.sharelinktechnologies.com/announcement/asx/bdead58cab7d3ffb990b6cb75825b87c	Annual Report Top 20 shareholders Full Year Accounts Full Year Audit Review Full Year Directors' Statement Full Year Directors' Report
2024-10-22 12:29:00	Appendix 4G and Corporate Governance Statement	0	https://app.sharelinktechnologies.com/announcement/asx/dce2489d836cf7dd8d2b6cf08510c846	Corporate Governance Takeover - Appendix 4G
2024-10-22 12:41:00	Notice of Annual General Meeting/Proxy Form	0	https://app.sharelinktechnologies.com/announcement/asx/ad918b214e792a919dd312860693cd86	Notice of Annual General Meeting Proxy Form Letter to Shareholders
2024-10-23 08:23:00	Annual Report filed on Form 20-F with SEC	0	https://app.sharelinktechnologies.com/announcement/asx/436489ad6f78a6af2e387a89ecf3487a	Annual Report Full Year Accounts Full Year Audit Review
2024-10-28 10:13:00	TACTI-003 Cohort B data to be presented at ESMO I-O	0	https://app.sharelinktechnologies.com/announcement/asx/e050e436bf0996785cf136ca905786ba	Company Administration - Other
2024-10-29 10:02:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/17b24af5b63ea015b6a3a964669d723f	Commitments Test Entity - First Quarter Report Commitments Test Entity - First Quarter Activity Report
2024-11-14 08:23:00	Becoming a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/1b908e43397437e50e4b773f23aa5a21	Becoming a substantial holder
2024-11-14 08:34:00	Positive Data from Phase II Trial in Soft Tissue Sarcoma	1	https://app.sharelinktechnologies.com/announcement/asx/0f6d1c814417fb302fc06b80e8e47d9e	Progress Report
2024-11-14 09:06:00	Excellent Survival Data from INSIGHT-003 Trial in NSCLC	1	https://app.sharelinktechnologies.com/announcement/asx/efc39c096a7bb9cb0fd41316401ec1c2	Progress Report
2024-11-18 16:52:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/b0f9d22a099a2c92b91fc43f3a85b8a1	Change in substantial holding
2024-11-22 08:18:00	Immutep AGM 2024 - CEO's Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/5a757a88a376466d93ac64bf07dd56fd	Company Presentation
2024-11-22 08:18:00	Immutep AGM 2024 - Chairman's Address	0	https://app.sharelinktechnologies.com/announcement/asx/1a4f6c708507bc46c2c664244c1d3ff6	Chairman's Address to Shareholders
2024-11-22 12:19:00	Results of Meeting	0	https://app.sharelinktechnologies.com/announcement/asx/0257b43fb8c332ea625f775284f4927b	Results of Meeting
2024-11-26 13:42:00	Immutep Investor Update	0	https://app.sharelinktechnologies.com/announcement/asx/292707e10c75ddd4ce16f16b4e93b5d1	Periodic Reports - Other Progress Report
2024-12-05 11:04:00	Notification regarding unquoted securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/164d141d5d42f34838bf376ace3687e0	Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2024-12-06 12:54:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/cc68a13774d84dd07a5792a131756aab	Appendix 2A (Application for Quotation of Securities
2024-12-10 09:43:00	Initiation of TACTI-004 phase 3 trial in 1st line NSCLC	1	https://app.sharelinktechnologies.com/announcement/asx/fe9462c7edac08d9e7af2283712a2194	Progress Report
2024-12-10 14:44:00	Change of Director's Interest Notice - M Voigt	0	https://app.sharelinktechnologies.com/announcement/asx/d278222c15f76c53291f9e9a084db163	Change of Director's Interest Notice
2024-12-10 14:45:00	Change of Director's Interest Notice - F Triebel	0	https://app.sharelinktechnologies.com/announcement/asx/b5357bc9269521bf71ad440aedb73692	Change of Director's Interest Notice
2024-12-10 14:46:00	Change of Director's Interest Notice - R Howard	0	https://app.sharelinktechnologies.com/announcement/asx/02d009d44ffd8dacd3a19fbf87b7b9a9	Change of Director's Interest Notice
2024-12-10 14:49:00	Change of Director's Interest Notice - L Boyce	0	https://app.sharelinktechnologies.com/announcement/asx/65a3650db1b170bd844b1d706c877e25	Change of Director's Interest Notice
2024-12-12 09:02:00	Immutep Reports Promising New Data in Head and Neck Cancer	1	https://app.sharelinktechnologies.com/announcement/asx/4f2657d1a9a2a7405782f13d0bf475ba	Progress Report
2024-12-13 12:09:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/5af808bc450746e7f61bd21090475d3e	Appendix 2A (Application for Quotation of Securities
2024-12-16 08:26:00	Publication Detailing How Human LAG-3 Binds to MHC Class II	0	https://app.sharelinktechnologies.com/announcement/asx/36eed4d754596a928687a5d818917ced	Progress Report
2024-12-17 08:20:00	Immutep announces initial safety data from IMP761 phase 1	1	https://app.sharelinktechnologies.com/announcement/asx/567616e64256773fbae87a3a06396ea9	Progress Report
2024-12-17 17:21:00	Notification of cessation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/c6e05082e2681b1c1f0f4ddbd5d10b59	Appendix 3H (Notification of cessation of securities)
2025-01-06 08:55:00	Patient Enrolment Completed for INSIGHT-003	0	https://app.sharelinktechnologies.com/announcement/asx/af62403513d58ccfdbd20a6f0526428d	Progress Report
2025-01-22 09:02:00	Enrolment completed for Ph II trial in Soft Tissue Sarcoma	0	https://app.sharelinktechnologies.com/announcement/asx/bc5d7cdcff027208cb04639a2c3ea159	Progress Report
2025-01-31 08:27:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/89f7899a443be301a212c8751db99a61	Commitments Test Entity - Second Quarter Report Commitments Test Entity - Second Quarter Activity Report
2025-02-05 11:37:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/43e801e9d57c39f42958009177daccea	Company Presentation
2025-02-06 18:03:00	Notification of cessation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/6e2c330c40761e10495a51842a540a14	Appendix 3H (Notification of cessation of securities)
2025-02-26 18:58:00	Half Yearly Report and Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/14fa7ee4e1f2d57b4d348c9c5f8e2cb5	Half Yearly Report Half Year Audit Review Half Year Directors' Statement Half Year Accounts Half Year Directors' Report
2025-03-20 10:29:00	TACTI-004 trial in progress poster to be presented at ELCC	0	https://app.sharelinktechnologies.com/announcement/asx/9327a9c3baf27cf0a8b9083e51cc938c	Company Administration - Other
2025-03-25 08:38:00	First patient dosed in phase 3 TACTI-004 lung cancer trial	1	https://app.sharelinktechnologies.com/announcement/asx/8362254961f3319e39bea0d1a3bfb767	Progress Report
2025-04-02 08:31:00	Immutep to Participate in Upcoming Investor Conferences	0	https://app.sharelinktechnologies.com/announcement/asx/4435ddb36cf7041058df465cfa647805	Company Administration - Other
2025-04-03 14:31:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/0edac415eea565880d062cb3ccb63724	Appendix 2A (Application for Quotation of Securities
2025-04-08 15:31:00	Change of Director's Interest Notice F Triebel	0	https://app.sharelinktechnologies.com/announcement/asx/35e707499eaa3f7bb2e19947849d4fd2	Change of Director's Interest Notice
2025-04-08 15:32:00	Change of Director's Interest Notice - M Voigt	0	https://app.sharelinktechnologies.com/announcement/asx/d2ca570fe3bf29729cb21aee1d1aa7eb	Change of Director's Interest Notice
2025-04-11 08:20:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/08ec4d827a686accd59f0fd9b4572d0c	Change in substantial holding
2025-04-23 10:24:00	Immutep Investor Update	0	https://app.sharelinktechnologies.com/announcement/asx/9be095e492507dee2d4e7565ccd37504	Periodic Reports - Other Progress Report
2025-04-29 09:02:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/8e27d8987e61776ab70a18fd64f28e37	Commitments Test Entity - Third Quarter Report Commitments Test Entity - Third Quarter Activity Report
2025-05-01 16:36:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/1e0b7ef777dc6073ef65cff60f977e4e	Change in substantial holding
2025-05-05 08:22:00	Excellent Overall Survival in Head & Neck Cancer Patients	1	https://app.sharelinktechnologies.com/announcement/asx/36f8811db1b59c48b4549d2db987bc75	Progress Report
2025-05-15 08:16:00	High Response Rates achieved in Lung Cancer in INSIGHT-003	1	https://app.sharelinktechnologies.com/announcement/asx/25674bf2c027d02adf5b0391c946f6e0	Progress Report
2025-05-26 08:22:00	Primary Endpoint Met in Phase II Soft Tissue Sarcoma Trial	1	https://app.sharelinktechnologies.com/announcement/asx/022d943cb0ccdc552f73e678bb1c2ac6	Progress Report
2025-06-02 08:21:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/e044181c5420c4410593b0f1f2b592f1	Company Presentation
2025-06-23 08:33:00	Update on Phase I Study of IMP761 for Autoimmune Diseases	1	https://app.sharelinktechnologies.com/announcement/asx/6cc1a51e0fc0dfec5e549e3968c33615	Progress Report
2025-06-30 16:39:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/2f22af211e20703475c7408565897810	Change in substantial holding
2025-07-17 08:19:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/8e3039aa74e94fc098b7c624b9634195	Change in substantial holding
2025-07-18 12:09:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/860d8ab027ed1eb84114647506366b60	Appendix 2A (Application for Quotation of Securities
2025-07-18 12:10:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/4cca40a473e63ea8d387c8f7ca4a1da9	Appendix 2A (Application for Quotation of Securities
2025-07-23 17:40:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/f74cd49d41da47a262c7e2a14e8f0f84	Ceasing to be a substantial holder
2025-07-25 08:16:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/673819b97b0242aeab69b28389a15751	Ceasing to be a substantial holder
2025-07-28 09:27:00	Abstracts Accepted for Presentation at ESMO Congress 2025	0	https://app.sharelinktechnologies.com/announcement/asx/17b5c52cd0b1366f90430c0dc8693171	Progress Report
2025-07-29 08:21:00	TACTI-004 trial in progress poster to be presented at WCLC	0	https://app.sharelinktechnologies.com/announcement/asx/a3acb8e1ab1cdd5a8aef4716e0a8c79d	Progress Report
2025-07-30 08:25:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/85e76cc941a5fdde0087c0d15d61a485	Commitments Test Entity - Fourth Quarter Report Commitments Test Entity - Fourth Quarter Activity Report
2025-08-05 09:26:00	FDA feedback received for head & neck cancer in CPS below 1	1	https://app.sharelinktechnologies.com/announcement/asx/79a2f52415da02bb80ed293967f9bbed	Progress Report